Your browser is no longer supported. Please, upgrade your browser.
Settings
AZN AstraZeneca PLC daily Stock Chart
AZN [NYSE]
AstraZeneca PLC
Index- P/E21.25 EPS (ttm)1.38 Insider Own0.50% Shs Outstand2.53B Perf Week0.72%
Market Cap74.31B Forward P/E14.93 EPS next Y1.97 Insider Trans0.00% Shs Float2.50B Perf Month13.56%
Income3.50B PEG2.76 EPS next Q- Inst Own13.50% Short Float0.99% Perf Quarter15.07%
Sales23.00B P/S3.23 EPS this Y23.80% Inst Trans-3.08% Short Ratio3.39 Perf Half Y-8.68%
Book/sh5.87 P/B5.00 EPS next Y7.66% ROA5.50% Target Price33.87 Perf Year4.70%
Cash/sh2.33 P/C12.59 EPS next 5Y7.70% ROE24.90% 52W Range24.73 - 33.47 Perf YTD11.07%
Dividend1.90 P/FCF- EPS past 5Y-17.60% ROI15.00% 52W High-12.24% Beta0.84
Dividend %6.47% Quick Ratio0.70 Sales past 5Y-7.30% Gross Margin82.60% 52W Low18.76% ATR0.43
Employees61500 Current Ratio0.90 Sales Q/Q-12.70% Oper. Margin21.30% RSI (14)71.43 Volatility1.02% 1.33%
OptionableYes Debt/Eq1.13 EPS Q/Q127.80% Profit Margin15.20% Rel Volume0.50 Prev Close29.35
ShortableYes LT Debt/Eq0.98 EarningsFeb 02 BMO Payout100.00% Avg Volume7.31M Price29.37
Recom2.20 SMA205.01% SMA507.74% SMA2002.04% Volume3,621,101 Change0.07%
Dec-09-16Upgrade Leerink Partners Mkt Perform → Outperform
Nov-25-16Upgrade Liberum Hold → Buy
Sep-23-16Initiated Piper Jaffray Overweight
Sep-12-16Upgrade Jefferies Hold → Buy
Aug-29-16Upgrade Argus Hold → Buy
Jul-12-16Initiated Argus Hold
Apr-12-16Downgrade Goldman Neutral → Sell
Mar-15-16Downgrade Jefferies Buy → Hold
Feb-26-16Initiated Cantor Fitzgerald Buy
Feb-08-16Downgrade HSBC Securities Buy → Hold
Jan-19-16Upgrade Barclays Underweight → Equal Weight
Dec-01-15Upgrade Morgan Stanley Underweight → Overweight
Nov-02-15Downgrade Nordea Buy → Hold
Oct-20-15Downgrade Credit Suisse Neutral → Underperform
Sep-18-15Upgrade Bryan Garnier Neutral → Buy
Jul-31-15Upgrade Swedbank Neutral → Buy
Jul-02-15Upgrade Berenberg Hold → Buy
Apr-15-15Initiated Societe Generale Buy
Sep-22-10Reiterated Barclays Capital Equal Weight $225 → $230
Jul-29-10Downgrade Standpoint Research Buy → Hold $60
Feb-27-17 04:05PM  AstraZenecas Segment-Wise Performance in Fiscal 2016
02:35PM  AstraZenecas 4Q16 Revenues Fell 12%
12:46PM  Changes in AstraZenecas Valuation in Fiscal 2016
12:42PM  AstraZeneca Has Started a Turnaround
08:28AM  Puma Biotechnology (PBYI) Q4 Earnings: What's in the Cards?
Feb-24-17 07:27AM  Pharma Stock Roundup: Is BMY the Next Acquisition Target? Priority Review for PFE, Novartis Drugs
Feb-23-17 09:24AM  Januvia and Janumet: Merck & Co.s Blockbuster Diabetes Products
Feb-22-17 10:37AM  Keytruda: Merck & Co.s Immuno-Oncology Blockbuster Drug
10:34AM  Ironwood (IRWD) Q4 Loss Narrower than Expected; Sales Top
09:08AM  Merck & Co.s Segment-Wise Revenues for 4Q16
07:29AM  Analyst: Buy AstraZeneca On The Turnaround Story
Feb-21-17 11:15AM  $250M deal: AstraZeneca sells rights to cancer therapy at bizjournals.com
09:30AM  The Zacks Analyst Blog Highlights: Merck, Valeant Pharmaceuticals International, Allergan, AstraZeneca and Johnson & Johnson
09:06AM  Sanofi Pasteur: Why Human Vaccines Matter
Feb-20-17 10:37AM  These Prescription Products Matter to Sanofis Growth
09:06AM  Sanofis Unique Foothold in Diabetes and Cardiovascular
Feb-17-17 04:31PM  AstraZeneca Could Give Pfizer, Tesaro Leg Up In Breast Cancer: Leerink
01:38PM  Clovis, Tesaro Soar on Astrazeneca Phase Three News
12:08PM  European Benchmarks Fall, But London Bucks Trend on Takeover Activity
10:22AM  [$$] AstraZeneca boosted by positive breast cancer trial at Financial Times
09:12AM  Valeant's (VRX) Plaque Psoriasis Drug Approved in the U.S.
08:05AM  AstraZeneca Stock Rises On Successful Breast Cancer Drug Trial
07:21AM  Pharma Stock Roundup: Merck's Alzheimer's Study Halted, Allergan to Buy ZELTIQ
07:09AM  FTSE 100 steps higher as pound falls on disappointing U.K. retail sales at MarketWatch
07:00AM  Merck, Bristol-Myers, Incyte Race For A Cure In $25 Billion I-O Market
07:00AM  LYNPARZA (olaparib) Meets Primary Endpoint in Phase III Trial in BRCA-Mutated Metastatic Breast Cancer Business Wire
Feb-16-17 04:41PM  Don't Count on Valeant's New Drug to Save the Day at Motley Fool
12:36PM  Top AstraZeneca shareholder Woodford adds to stake, bullish on outlook
12:05PM  Why This FDA Approval for Valeant Is Not as Good as First Thought
10:38AM  Valeant Pharmaceuticals: Dead in the Water? at Barrons.com
07:00AM  Valeant Receives FDA Approval Of SILIQ (Brodalumab) For Moderate-To-Severe Plaque Psoriasis PR Newswire
Feb-15-17 05:03PM  Price Bump From M&A Rumors Earns Acadia A Vetr Downgrade
04:18PM  Merck's Alzheimer's Drug Fails; Are Biogen, Roche, AstraZeneca Next?
10:42AM  Eli Lilly Is Great Stock to Buy Now
10:01AM  China MediTech And AstraZeneca PLC (ADR) (AZN) To Present Savolitinib Phase II Results At The Genitourinary Cancers Symposium 2017 at Insider Monkey
Feb-14-17 03:10PM  Stock Research Reports for Union Pacific, ConocoPhillips & Emerson Electric
02:39PM  ETFs with exposure to AstraZeneca Plc : February 14, 2017
09:32AM  Lilly's Olumiant Gets Marketing Authorization in Europe
05:16AM  Chi-Med and AstraZeneca Present Savolitinib Papillary Renal Cell Carcinoma Phase II Results at 2017 Genitourinary Cancers Symposium Business Wire
03:05AM  These drug and medical device companies made the most payments to Chicago hospitals at bizjournals.com
Feb-10-17 11:30AM  Sanofi -- Moody's: Pipelines are biggest credit quality hope for Europe's Pharma sector in 2017 at Moody's
Feb-09-17 01:15PM  Bladder Cancer Drug Competition Ramps Up at Investopedia
Feb-07-17 02:13PM  AstraZeneca Plc :AZN-US: Earnings Analysis: 2016 By the Numbers : February 7, 2017
Feb-06-17 12:45PM  Dodge & Cox Comments on AstraZeneca
10:49AM  AstraZeneca Plc :AZN-US: Earnings Analysis: Q4, 2016 By the Numbers : February 6, 2017
06:22AM  Brexit Already Having a Negative Impact, Business Leaders Say
Feb-03-17 04:29PM  AstraZeneca Shrugs Off Bristol-Myers' Setback; Crushes Q4 Views
01:29PM  Acadia Pops on Takeout Rumors, But Don't Buy on M&A Just Yet
08:09AM  AstraZeneca (AZN) Beats on Q4 Earnings but Misses on Sales
Feb-02-17 04:51PM  Biogen Trails Merck, Lilly In Alzheimer's; Hemophilia Spinoff Begins Trading
01:05PM  [$$] AstraZeneca: faith healer at Financial Times
12:20PM  AstraZeneca flags tough 2017, yet confident on key cancer trial
11:13AM  [$$] AstraZeneca hit by falling sales of its bestselling drugs at Financial Times
10:17AM  Agilent (A) Announces Expanded Use of Diagnostic Assay
07:41AM  AstraZeneca Provides Cautious 2017 Guidance at TheStreet
06:02AM  Astrazeneca posts 4Q profit
04:39AM  [$$] AstraZeneca Net Profit Boosted by Licensing Deals at The Wall Street Journal
03:49AM  AstraZeneca Falls After Cautious 2017 Outlook as Crestor Sales Slow
03:04AM  AstraZeneca says fourth-quarter revenue fell 13 percent
02:13AM  AstraZeneca faces falling 2017 profits as key drug data awaited
Feb-01-17 03:11PM  Top 6 Earnings To Watch For On Thursday
Jan-31-17 12:59PM  Clovis Oncology Inc (CLVS)s Ovarian Cancer Drug Faces Stiff Competition From AstraZeneca PLC (ADR) (AZN), TESARO Inc (TSRO) at Insider Monkey
09:48AM  Trump says drug prices are 'astronomical' at MarketWatch
Jan-30-17 04:12PM  Tesaro, AstraZeneca Could Shrink Clovis' Ovarian Cancer Drug Pool
11:33AM  AstraZeneca PLC (ADR) (AZN) Wins A Six Months Paediatric Exclusivity Approval Of Its Symbicort at Insider Monkey
07:00AM  FibroGens Roxadustat (FG-4592) Meets Primary Endpoints in Two Phase 3 Anemia Studies in China GlobeNewswire
Jan-28-17 04:58PM  Can Novavax Stay Ahead of the Competition? at Motley Fool
Jan-27-17 05:36PM  AstraZeneca's Symbicort Granted Pediatric Exclusivity by FDA
04:37PM  Will Merck Let Incyte Go After AstraZeneca, Bristol, Roche Team-Ups Too?
12:20PM  AstraZenecas Symbicort Gets Pediatric Exclusivity (AZN) at Investopedia
10:36AM  What Recent Developments Could Drive Eli Lillys Growth?
08:41AM  Microsoft (MSFT) Beats on Q2 Earnings, Revenue Estimates
Jan-26-17 03:28PM  Here's the Reason Behind TESARO Inc.'s Sudden 12% Move Higher at Motley Fool
09:05AM  SCYNEXIS Announces Appointment of Industry Veteran Marion McCourt to its Board of Directors GlobeNewswire
08:25AM  Drug Giants May Benefit From China Drug Inclusion at Investopedia
Jan-25-17 02:40PM  Which Pharma Players Dominate The Lung Cancer Space?
Jan-20-17 04:53PM  Bristol-Myers lung cancer delay slams shares, keeps Merck in lead
11:11AM  Bristol-Myers tight-lipped pass on accelerated lung cancer drug approval leaves field wide open for Merck at MarketWatch
08:15AM  Blog Coverage AbbVie Received FDA Approval for Treatment for Marginal Zone Lymphoma Accesswire
Jan-19-17 12:56PM  [$$] GSK appoints AstraZeneca executive as global head of pharma at Financial Times
07:00AM  This Could Be The Biggest Winner Of 2017s Biotech Boom
05:13AM  GSK grabs Astra executive to replace pharma head
Jan-18-17 08:30AM  AstraZeneca Offers Update on Immuno-Oncology Program
Jan-17-17 04:32PM  FDA Track Record Bodes Well For Merck Keytruda Plus Chemo: Leerink
08:54AM  [$$] AstraZeneca expands trials for key cancer drug at Financial Times
Jan-16-17 12:04PM  Dodge & Cox's Stock Fund 4th Quarter Commentary
Jan-12-17 04:04PM  Bristol-Myers Threatens Merck's 'Head Start' In Lung Cancer: Analyst
10:37AM  Mylans Specialty Segment: The Effect of Falling EpiPen Sales
04:47AM  European Pharma Shares Hammered After Trump Press Conference Attack
Jan-11-17 04:33PM  Bristol-Myers and AstraZeneca Take Beatings
01:03PM  2 Stocks For a Trump-ed Up Pharma Market at Barrons.com
12:28PM  Merck Lung-Cancer Drug May Get OK For Large Patient Population
12:09PM  European stocks trim gains after Trump comments send drug stocks lower at MarketWatch
Jan-10-17 09:30AM  Can AstraZeneca (AZN) Be a Solid Choice for Value Investors?
Jan-09-17 06:51PM  [$$] Chance for an agile new drug approval system at Financial Times
05:30PM  Mysterious $5 Billion Biotech Firm Moderna Lays Out Drug Pipeline at Forbes
01:33PM  Bullish and Bearish Reversals in the Market
Jan-05-17 11:04AM  Shell, AstraZeneca Could Surprise in 2017, Credit Suisse Says
Jan-04-17 12:00PM  Here's Why General Motors Is One of Wednesday's Most Active Stocks
Jan-03-17 01:43PM  AstraZeneca PLC (ADR) (AZN) Planning Tagrisso Label Expansion To Shore Up Earnings at Insider Monkey
AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for the treatment of respiratory, inflammation, autoimmune, cardiovascular, metabolic, oncology, infection, neuroscience, and gastrointestinal diseases worldwide. Its marketed products comprise Accolate, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp, Duaklir Genuair, Eklira Genuair/Tudorza/Bretaris, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Rhinocort, Symbicort pMDI, and Symbicort Turbuhaler for respiratory, inflammation, and autoimmunity diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor2, Plendil, Seloken/Toprol-XL, Tenormin3, and Zestril4 for cardiovascular disease; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Symlin, Xigduo, and Xigduo XR for metabolic disease. The company's marketed products also include Arimidex, Faslodex, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex, as well as Casodex, Cosudex for oncology disease; Fluenz/FluMist, Fluenz Tetra/FluMist Quadrivalent1, Merrem/Meronem2, Synagis3, and Zinforo4 for infection disease; Diprivan, EMLA, Movantik/Moventig, Naropin, Seroquel IR, Seroquel XR, Vimovo1, Xylocaine, and Zomig for neuroscience disease; and Losec/Prilosec and Nexium for gastrointestinal disease. It serves primary care and specialty care physicians through distributors and local representative offices. The company's pipeline includes 146 projects, of which 125 are in the clinical phase of development. It has collaboration agreements with Celgene Corporation; Immunocore Limited; Heptares Ltd.; Foundation Medicine, Inc., French National Institute of Health and Medical Research (Inserm); and FibroGen and Astellas, as well as a research agreement with Eli Lilly. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in London, the United Kingdom.
EBAY eBay Inc. daily Stock Chart
EBAY [NASD]
eBay Inc.
IndexS&P 500 P/E5.29 EPS (ttm)6.48 Insider Own6.60% Shs Outstand1.07B Perf Week1.54%
Market Cap36.76B Forward P/E15.47 EPS next Y2.22 Insider Trans-0.70% Shs Float1.01B Perf Month8.00%
Income7.29B PEG0.72 EPS next Q0.48 Inst Own86.80% Short Float1.79% Perf Quarter18.62%
Sales8.98B P/S4.09 EPS this Y299.00% Inst Trans-3.14% Short Ratio1.76 Perf Half Y9.38%
Book/sh9.55 P/B3.59 EPS next Y10.03% ROA34.60% Target Price34.41 Perf Year41.77%
Cash/sh6.65 P/C5.16 EPS next 5Y7.32% ROE96.50% 52W Range22.30 - 34.23 Perf YTD15.46%
Dividend- P/FCF16.71 EPS past 5Y21.00% ROI30.60% 52W High0.15% Beta1.26
Dividend %- Quick Ratio2.30 Sales past 5Y-5.10% Gross Margin77.60% 52W Low53.72% ATR0.61
Employees12600 Current Ratio2.30 Sales Q/Q3.10% Oper. Margin25.90% RSI (14)69.06 Volatility1.51% 1.72%
OptionableYes Debt/Eq0.85 EPS Q/Q1144.40% Profit Margin80.90% Rel Volume0.72 Prev Close34.06
ShortableYes LT Debt/Eq0.71 EarningsJan 25 AMC Payout0.00% Avg Volume10.27M Price34.28
Recom2.60 SMA203.67% SMA509.55% SMA20017.57% Volume7,372,912 Change0.65%
Feb-17-17Resumed Pacific Crest Sector Weight
Jan-26-17Reiterated Stifel Hold $31 → $35
Jan-26-17Reiterated RBC Capital Mkts Sector Perform $32 → $34
Jan-26-17Reiterated Aegis Capital Buy $36 → $38
Jan-24-17Reiterated The Benchmark Company Buy $39 → $37
Jan-03-17Resumed Piper Jaffray Neutral $28
Jan-03-17Initiated Aegis Capital Buy $36
Oct-21-16Upgrade Hilliard Lyons Long-term Buy → Buy
Oct-20-16Reiterated Wedbush Neutral $34 → $33
Oct-20-16Reiterated Mizuho Neutral $31 → $32
Oct-18-16Reiterated Monness Crespi & Hardt Buy $32 → $35
Oct-17-16Reiterated The Benchmark Company Buy $33 → $38
Oct-13-16Resumed Wedbush Neutral $34
Sep-29-16Upgrade Deutsche Bank Hold → Buy $30 → $40
Sep-14-16Reiterated Axiom Capital Buy $34 → $38
Sep-13-16Reiterated Axiom Capital Buy $34 → $38
Aug-30-16Initiated Hilliard Lyons Long-term Buy $35
Jul-21-16Reiterated The Benchmark Company Buy $29 → $33
Jul-21-16Reiterated RBC Capital Mkts Sector Perform $28 → $31
Jul-21-16Reiterated Monness Crespi & Hardt Buy $29 → $32
Feb-27-17 05:35PM  Former eBay CEO named chief executive of ServiceNow at bizjournals.com
04:10PM  IMPORTANT SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against PayPal Holdings, Inc., and eBay, Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
03:48PM  FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against PayPal Holdings, Inc. (PYPL) & eBay, Inc. (EBAY) & Lead Plaintiff Deadline: February 27, 2017 Accesswire
12:08PM  ServiceNow CEO Shuffle Surprises, Stock Falls
Feb-24-17 09:12PM  SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against PayPal Holdings Inc., and eBay Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
08:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in PayPal Holdings, Inc., eBay, Inc. of Class Action Lawsuit and Upcoming Deadline - PYPL, EBAY Accesswire
03:29PM  Apple, eBay, IBM Just a Few Names Sticking Up For Transgender Rights
03:11PM  Nasty Gal: From $85 Million to Bankruptcy at MarketWatch
10:24AM  IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against PayPal Holdings, Inc., and eBay, Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
10:06AM  UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of PayPal Holdings, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 27, 2017 - PYPL PR Newswire
09:20AM  7 Ultra-Cheap Value Stocks to Buy Now at Kiplinger
Feb-23-17 10:35AM  INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against PayPal Holdings Inc., and eBay Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
10:10AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against PayPal Holdings, Inc. (PYPL) & eBay, Inc. (EBAY) & Lead Plaintiff Deadline: February 27, 2017 GlobeNewswire
Feb-22-17 05:00PM  Why Is EBay Returning to China?
02:05PM  Can Seagate Keep Beating Expectations?
12:31PM  Reading the Signs of eBays Earnings Data
Feb-21-17 05:11PM  Wal-Mart keeps working to make inroads against Amazon
11:07AM  IMPORTANT EQUITY NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against PayPal Holdings, Inc., and eBay, Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
10:28AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against PayPal Holdings, Inc. (PYPL) and eBay, Inc. (EBAY) and Lead Plaintiff Deadline: February 27, 2017 Accesswire
08:00AM  eBay Partners with Snupps, A Social Organizing App, for Seamless Selling PR Newswire
Feb-19-17 07:32AM  Thousands On eBay Make Money On Trump
Feb-17-17 08:22PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against PayPal Holdings Inc., and eBay Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
08:05PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in PayPal Holdings, Inc., eBay, Inc. of Class Action Lawsuit and Upcoming Deadline - PYPL, EBAY Accesswire
06:09AM  [$$] The art of parquetry: building blocks to a perfect floor at Financial Times
Feb-16-17 03:55PM  IMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against PayPal Holdings, Inc., and eBay, Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
03:26PM  DEADLINE ALERT: Brower Piven Reminds Investors Of The February 27, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess of $100,000 From Investment In PayPal Holdings, Inc. To Contact The Firm Business Wire
09:52AM  Groupon (GRPN) Q4 Earnings and Revenues Beat Estimates
08:00AM  eBay Advertising Survey Reveals Behavioral Shifts in Online Car Buying PR Newswire
Feb-15-17 01:27PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against PayPal Holdings Inc., and eBay Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
11:34AM  The 'stock market for sneakers' just scored an all-star lineup of new investors
10:45AM  PYPL INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving PayPal Holdings, Inc. and a Lead Plaintiff Deadline of February 27, 2017 PR Newswire
Feb-14-17 02:05PM  Should eBay Be Doing More to Stop Sales of Fakes?
Feb-13-17 07:01PM  The Single Most Important Quote From eBay Inc's Latest Investor Call at Motley Fool
12:01PM  Aeropost.com And eBay Partner To Provide Latin American Shoppers Seamless Access To Millions Of Products PR Newswire
11:03AM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against PayPal Holdings, Inc., and eBay, Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
10:35AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against PayPal Holdings, Inc. (PYPL) and eBay, Inc. (EBAY) and Lead Plaintiff Deadline: February 27, 2017 Accesswire
10:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in PayPal Holdings, Inc., eBay, Inc. of Class Action Lawsuit and Upcoming Deadline PYPL, EBAY GlobeNewswire
08:34AM  Here's Why eBay Is Partnering With WineDirect at Forbes
Feb-12-17 05:22PM  Forget eBay Inc.: These 2 Stocks Are Better Buys at Motley Fool
Feb-10-17 01:04PM  EBAY INC Financials
12:51PM  Unusual activity: Bulls bidding on eBay
12:32PM  IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against PayPal Holdings Inc., and eBay Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
07:20AM  With 1,462 Tom Brady Jerseys on eBay, Which One to Pick?
Feb-09-17 06:27PM  Is the PayPal Killer Lurking?
11:08AM  IMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against PayPal Holdings, Inc., and eBay, Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
10:30AM  Investor Alert: GPM Reminds Investors of the February 27 Deadline in the Class Action Lawsuit Against PayPal Holdings, Inc. and eBay, Inc. Business Wire
09:00AM  PAYPAL: Rosen Law Firm Reminds PayPal Holdings, Inc. Investors of Feb. 27 Deadline in Class Action PYPL, EBAY GlobeNewswire
Feb-08-17 07:53PM  Amazon and Apple's Payments Growth Shows PayPal Is Facing Stiffer Competition
02:47PM  Indiegogo CEO: Silicon Valley is an 'echo chamber'
11:34AM  An Amazon-PayPal Partnership Still Doesn't Make Sense at Motley Fool
09:56AM  Tom Brady wont find his missing jersey if he keeps looking on eBay at MarketWatch
06:25AM  Who Does Apple Say It Competes With?
Feb-07-17 12:00PM  Harambe-shaped Cheeto sold for almost $100,000 at CNBC
11:53AM  The founder of eBay is investing nearly $500,000 to test giving people free money
10:00AM  eBay Partners With WineDirect To Support Thousands Of Small And Medium Sized Wineries And Grows The Wine Marketplace For Consumers PR Newswire
Feb-06-17 06:06PM  EBay finds 'material weakness' in controls over accounting for tax
11:51AM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against PayPal Holdings Inc., and eBay Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
10:29AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against PayPal Holdings, Inc. (PYPL) and eBay, Inc. (EBAY) and Lead Plaintiff Deadline: February 27, 2017 Accesswire
10:02AM  Apple, Microsoft Join 97 Tech Companies Opposing Trump's Immigration Ban in Court
Feb-03-17 05:43PM  International Audience Willing To Travel For Super Bowl 51 at Forbes
12:21PM  How Analytics Helped eBay Tackle Worker Retention at The Wall Street Journal
Feb-02-17 11:28AM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against PayPal Holdings, Inc., and eBay, Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
10:30AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against PayPal Holdings, Inc. (PYPL) and eBay, Inc. (EBAY) and Lead Plaintiff Deadline: February 27, 2017 Accesswire
08:15AM  Post Earnings Coverage as eBay's Revenue Rose 6% on Currency Neutral Basis; Non-GAAP EPS Gained 8% Accesswire
Feb-01-17 05:45PM  Alibabas Ma-Trump Meeting: More Than Meets the Eye?
04:45PM  eBay And Amazon: Hunting For Pairs During Earnings Season
04:37PM  Inside The Billion Dollar Industry Of China's Most Famous Social Media Celebrities
12:26PM  IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against PayPal Holdings Inc., and eBay Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
10:21AM  PYPL INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving PayPal Holdings, Inc. and a Lead Plaintiff Deadline of February 27, 2017 GlobeNewswire
07:46AM  10 Largest Online Shopping Sites In The World at Insider Monkey
06:00AM  Ticketbis Rebranded to StubHub PR Newswire
Jan-31-17 06:21PM  Without Immigrants, These Companies Wouldn't Exist
03:34PM  Meg Whitman, husband join Sacramento Republic ownership group at bizjournals.com
02:38PM  Some Very Special Sauce at The Wall Street Journal
10:36AM  Super Bowl ticket prices are plummeting heres the smart way to buy
08:15AM  Post Earnings Coverage as Alibaba's Q3 Top-line Surged 54%; Outshined Forecasts Accesswire
Jan-30-17 01:15PM  Investors Bullish on Alphabet and Bitcoin, According to Tradebird at TheStreet
12:51PM  Q4 Earnings Scorecard and Analyst Reports for Ford, Microsoft & United Technologies
10:58AM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against PayPal Holdings, Inc., and eBay, Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
10:29AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against PayPal Holdings, Inc. (PYPL) and eBay, Inc. (EBAY) and Lead Plaintiff Deadline - February 27, 2017 Accesswire
Jan-27-17 08:07PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in PayPal Holdings, Inc., eBay, Inc. of Class Action Lawsuit and Upcoming Deadline - PYPL, EBAY Accesswire
01:04PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against PayPal Holdings, Inc., and eBay, Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
12:17PM  $100,000 for Big Mac sauce? Limited edition bottles hit eBay at CNBC
11:55AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of PayPal Holdings, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 27, 2017 PYPL GlobeNewswire
11:11AM  eBay is on the upswing
10:50AM  PayPal Failing to Match Parent eBay's Hot Streak at Investopedia
10:13AM  Silicon Valleys week in earnings: 4 big winners (and 3 losers) at bizjournals.com
07:25AM  eBay Earnings Beat, Retail Trends Suggest More Growth Ahead
03:26AM  Dow notches fresh record, but S&P 500, Nasdaq flounder at MarketWatch
Jan-26-17 10:30PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In PayPal Holdings, Inc. (PYPL) And eBay, Inc. (EBAY) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Laws GlobeNewswire
07:36PM  [$$] PayPal Results Climb on Increased Customers, Transactions at The Wall Street Journal
05:42PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against PayPal Holdings Inc., and eBay Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
04:31PM  AT&T, eBay PTs Raised; J&J, United Tech, Mattel Downgraded
04:10PM  Analysts look for catalysts as eBay sees slow but steady improvements at MarketWatch
04:01PM  EBay Breaks Out As Earnings Spark Numerous Price-Target Hikes
03:18PM  EBay beats analysts' estimates for Q4, gets stock boost at bizjournals.com
02:22PM  eBay Stock Soars on So-So Earnings at Investopedia
01:39PM  eBay's Makeover Starts to Show Signs of Paying Off
12:13PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against PayPal Holdings, Inc. - PYPL GlobeNewswire
11:43AM  EBay shares jump after earnings beat at Silicon Beat
eBay Inc. operates commerce platforms that connect various buyers and sellers worldwide. Its platforms enable sellers to organize and offer their inventory for sale; and buyers to find and purchase it virtually. The company's Marketplace platforms include its online marketplace at ebay.com and the eBay mobile apps; and StubHub platforms comprise its online ticket platform at stubhub.com, and the StubHub mobile apps and Ticketbis platforms that connect fans with their favorite sporting events, shows, and artists, as well as enables them to buy and sell tickets. Its Classifieds platforms include a collection of brands, such as mobile.de, Kijiji, Gumtree, Marktplaats, eBay Kleinanzeigen, and others, which offer online classifieds to enable people find whatever they are looking for in their local communities. The company's platforms enable users to find, buy, sell, and pay for items through various online, mobile, and offline channels that include retailers, distributors, liquidators, import and export companies, auctioneers, catalog and mail-order companies, classifieds, directories, search engines, commerce participants, shopping channels, and networks. eBay Inc. was founded in 1995 and is headquartered in San Jose, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lawton III Harry ASVP, North AmericaFeb 23Sale33.7313,400451,92214,520Feb 27 07:49 PM
FISHER STEPHENSVP, CTOFeb 22Option Exercise21.6416,543358,02199,657Feb 23 06:33 PM
FISHER STEPHENSVP, CTOFeb 22Sale33.7716,601560,62189,687Feb 23 06:33 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerFeb 17Option Exercise23.0810,974253,27885,966Feb 21 07:40 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerFeb 17Sale33.6630,0101,010,00477,879Feb 21 07:40 PM
Lee Jae HyunSVP, Asia PacificFeb 16Sale34.118,000272,88483,222Feb 21 07:35 PM
Doerger Brian J.VP, Chief Accounting OfficerFeb 09Sale33.256,660221,43229,006Feb 10 05:21 PM
TIERNEY THOMAS JDirectorFeb 08Option Exercise9.856,01459,23828,525Feb 09 07:38 PM
Lee Jae HyunSVP, eBay Marketplaces AsiaFeb 08Option Exercise22.6253,1271,201,614117,972Feb 10 05:15 PM
TIERNEY THOMAS JDirectorFeb 08Sale33.286,014200,15722,511Feb 09 07:38 PM
Lee Jae HyunSVP, eBay Marketplaces AsiaFeb 08Sale32.7853,1271,741,57291,222Feb 10 05:15 PM
SWAN ROBERT HOLMESDirectorJan 30Option Exercise22.69125,6082,850,288442,401Jan 31 06:03 PM
SWAN ROBERT HOLMESDirectorJan 30Sale32.00200,6086,418,532301,633Jan 31 06:03 PM
Yetto Kristin ASVP, Chief People OfficerDec 15Option Exercise0.003,126023,966Dec 16 07:57 PM
FISHER STEPHENSVP, CTODec 15Option Exercise0.007,294093,552Dec 16 07:51 PM
WENIG DEVINPresident and CEODec 15Option Exercise0.0013,0860472,666Dec 16 07:47 PM
Schenkel Scott F.Chief Financial OfficerDec 15Option Exercise0.006,2520104,017Dec 19 07:48 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerDec 15Option Exercise0.00137,6430169,703Dec 19 07:38 PM
Lee Jae HyunSVP, Asia PacificDec 15Option Exercise0.003,126091,222Dec 19 07:32 PM
Doerger Brian J.VP, Chief Accounting OfficerDec 15Option Exercise0.0018,487045,313Dec 19 07:28 PM
Lawton III Harry ASVP, North AmericaDec 15Option Exercise0.003,647029,824Dec 19 07:23 PM
Huber Marie OhSVP, GC and SecretaryDec 15Option Exercise0.002,501022,079Dec 19 07:17 PM
Todd Jeremy PaulSVP, EMEADec 15Option Exercise0.002,084069,233Dec 19 07:09 PM
Doerger Brian J.VP, Chief Accounting OfficerNov 21Option Exercise22.8818,000411,87644,826Nov 23 07:13 PM
Doerger Brian J.VP, Chief Accounting OfficerNov 21Sale28.9318,000520,79626,826Nov 23 07:13 PM
Green LoganDirectorNov 02Buy28.321,00028,3211,000Nov 03 08:02 PM
FISHER STEPHENSVP, CTOOct 25Option Exercise21.6412,408268,532120,563Oct 26 07:50 PM
FISHER STEPHENSVP, CTOOct 25Sale29.2039,7641,161,10986,258Oct 26 07:50 PM
FISHER STEPHENSVP, CTOOct 15Option Exercise0.00106,5490169,212Oct 17 06:42 PM
Schenkel Scott F.SVP, Chief Financial OfficerOct 15Option Exercise0.005,9070100,848Oct 17 06:37 PM
WENIG DEVINPresident and CEOOct 15Option Exercise0.0013,8980466,832Oct 17 06:32 PM
Yetto Kristin ASVP, Chief People OfficerSep 15Option Exercise0.003,126022,472Sep 19 06:23 PM
Todd Jeremy PaulSVP, EMEASep 15Option Exercise0.002,084068,280Sep 19 06:06 PM
Schenkel Scott F.SVP, Chief Financial OfficerSep 15Option Exercise0.006,252098,204Sep 19 06:00 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerSep 15Option Exercise0.005,731035,051Sep 19 05:54 PM
Lee Jae HyunSVP, Asia PacificSep 15Option Exercise0.003,126088,096Sep 19 05:49 PM
Lawton III Harry ASVP, North AmericaSep 15Option Exercise0.003,647028,081Sep 19 05:44 PM
Huber Marie OhSVP, GC and SecretarySep 15Option Exercise0.002,500020,883Sep 19 05:32 PM
FISHER STEPHENSVP, CTOSep 15Option Exercise0.007,294066,470Sep 19 05:22 PM
Doerger Brian J.VP, Chief Accounting OfficerSep 15Option Exercise0.004,558029,205Sep 19 05:16 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerAug 31Option Exercise22.7141,880951,13948,779Sep 01 05:49 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerAug 31Sale32.1439,0301,254,56526,980Sep 01 05:49 PM
Lee Jae HyunSVP, Asia PacificAug 31Sale31.8516,559527,42684,970Sep 02 04:58 PM
SWAN ROBERT HOLMESDirectorAug 30Sale31.9550,0001,597,500375,928Sep 01 05:27 PM
Lee Jae HyunSVP, Asia PacificAug 24Sale31.025,625174,488101,529Aug 26 06:40 PM
Todd Jeremy PaulSVP, EMEAAug 10Option Exercise0.0032,935084,065Aug 12 05:06 PM
Lee Jae HyunSVP, Asia PacificJul 27Sale31.533,222101,590107,154Jul 28 08:15 PM
Lee Jae HyunSVP, Asia PacificJul 26Sale31.0310,601328,949110,376Jul 27 06:40 PM
Doerger Brian J.VP, Chief Accounting OfficerJul 25Option Exercise22.6313,608307,94948,605Jul 27 06:19 PM
TIERNEY THOMAS JDirectorJul 25Option Exercise9.858,00078,80025,545Jul 27 07:13 PM
FISHER STEPHENSVP, CTOJul 25Option Exercise21.6437,223805,57797,032Jul 27 06:58 PM
TIERNEY THOMAS JDirectorJul 25Sale30.658,000245,20017,545Jul 27 07:13 PM
Lee Jae HyunSVP, Asia PacificJul 25Sale30.741,16735,878120,977Jul 27 06:40 PM
Yetto Kristin ASVP, Chief People OfficerJul 25Sale30.7917,596541,83419,346Jul 27 06:34 PM
Doerger Brian J.VP, Chief Accounting OfficerJul 25Sale30.5623,958732,26424,647Jul 27 06:19 PM
SWAN ROBERT HOLMESDirectorJul 25Sale30.6550,0001,532,340425,288Jul 27 07:06 PM
FISHER STEPHENSVP, CTOJul 25Sale30.6553,3891,636,16959,176Jul 27 06:58 PM
Schenkel Scott F.SVP, Chief Financial OfficerJul 17Option Exercise0.001,768092,875Jul 18 08:27 PM
WENIG DEVINPresident and CEOJul 17Option Exercise0.005,8950449,754Jul 18 07:55 PM
Lawton III Harry ASVP, N.A.Jun 15Option Exercise0.0042,723039,075Jun 17 07:57 PM
Lee Jae HyunSVP, Asia PacificJun 15Option Exercise0.003,1270122,144Jun 17 07:53 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerJun 15Option Exercise0.005,732029,461Jun 17 07:50 PM
Doerger Brian J.VP, Chief Accounting OfficerJun 15Option Exercise0.004,559037,376Jun 17 07:46 PM
Todd Jeremy PaulSVP, EMEAJun 15Option Exercise0.0014,501057,098Jun 17 07:42 PM
WENIG DEVINPresident and CEOJun 15Option Exercise0.0013,0870450,688Jun 17 08:18 PM
Schenkel Scott F.SVP, Chief Financial OfficerJun 15Option Exercise0.006,253094,370Jun 17 08:15 PM
Huber Marie OhSVP, GC & SecretaryJun 15Option Exercise0.0031,556029,055Jun 17 08:10 PM
Yetto Kristin ASVP, Chief People OfficerJun 15Option Exercise0.0015,543041,926Jun 17 08:04 PM
FISHER STEPHENSVP, CTOJun 15Option Exercise0.007,295079,149Jun 16 08:42 PM
Doerger Brian J.VP, Chief Accounting OfficerJun 08Option Exercise0.0011,388038,760Jun 09 05:22 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerMay 27Sale24.2425,000605,89823,729Jun 01 04:28 PM
Doerger Brian J.VP, Chief Accounting OfficerMay 24Option Exercise16.6814,474241,42641,846May 24 08:58 PM
Doerger Brian J.VP, Chief Accounting OfficerMay 24Sale24.0814,474348,53427,372May 24 08:58 PM
Doerger Brian J.VP, Chief Accounting OfficerMay 09Option Exercise16.6820,000333,60047,372May 10 07:49 PM
Doerger Brian J.VP, Chief Accounting OfficerMay 09Sale24.0320,000480,65027,372May 10 07:49 PM
Yetto Kristin ASVP, Chief People OfficerApr 29Sale24.1110,630256,30428,343May 03 07:29 PM
Yetto Kristin ASVP, Chief People OfficerApr 01Option Exercise0.0027,861052,553Apr 05 08:01 PM
WENIG DEVINPresident and CEOApr 01Option Exercise0.0078,0130477,120Apr 05 07:59 PM
Todd Jeremy PaulSVP, EMEAApr 01Option Exercise0.0017,168052,659Apr 05 07:49 PM
Schenkel Scott F.SVP, Chief Financial OfficerApr 01Option Exercise0.0025,0330100,013Apr 05 07:48 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerApr 01Option Exercise0.0010,973053,026Apr 05 07:47 PM
Lee Jae HyunSVP, Asia PacificApr 01Option Exercise0.0016,1830117,850Apr 05 07:36 PM
FISHER STEPHENSVP, CTOApr 01Option Exercise0.0010,919077,552Apr 05 07:35 PM
Doerger Brian J.VP, Chief Accounting OfficerApr 01Option Exercise0.0025,327036,892Apr 05 07:33 PM
EPD Enterprise Products Partners L.P. daily Stock Chart
EPD [NYSE]
Enterprise Products Partners L.P.
Index- P/E22.66 EPS (ttm)1.23 Insider Own0.20% Shs Outstand2.14B Perf Week-3.74%
Market Cap59.38B Forward P/E17.96 EPS next Y1.55 Insider Trans0.87% Shs Float1.41B Perf Month-6.97%
Income2.53B PEG3.13 EPS next Q0.33 Inst Own37.20% Short Float0.96% Perf Quarter7.97%
Sales22.70B P/S2.62 EPS this Y-20.90% Inst Trans2.69% Short Ratio2.64 Perf Half Y5.23%
Book/sh10.45 P/B2.66 EPS next Y11.21% ROA4.90% Target Price32.69 Perf Year20.63%
Cash/sh- P/C- EPS next 5Y7.24% ROE11.50% 52W Range22.64 - 30.25 Perf YTD2.74%
Dividend1.64 P/FCF- EPS past 5Y-3.30% ROI7.80% 52W High-8.17% Beta0.88
Dividend %5.90% Quick Ratio0.60 Sales past 5Y-12.30% Gross Margin15.10% 52W Low22.70% ATR0.48
Employees6800 Current Ratio0.80 Sales Q/Q5.30% Oper. Margin15.80% RSI (14)40.12 Volatility1.45% 1.59%
OptionableYes Debt/Eq1.07 EPS Q/Q-49.30% Profit Margin11.00% Rel Volume0.55 Prev Close27.93
ShortableYes LT Debt/Eq0.96 EarningsJan 30 BMO Payout132.30% Avg Volume5.13M Price27.78
Recom1.60 SMA20-2.78% SMA500.08% SMA2001.83% Volume2,799,956 Change-0.54%
Jan-31-17Reiterated Barclays Overweight $31 → $33
Nov-16-16Initiated Ladenburg Thalmann Buy
Sep-30-16Initiated Mizuho Buy $32
Sep-19-16Upgrade Credit Suisse Neutral → Outperform
Aug-31-16Reiterated Wunderlich Buy $33 → $32
Aug-18-16Downgrade Morgan Stanley Overweight → Equal-Weight
May-11-16Initiated Bernstein Outperform $33
Apr-29-16Downgrade Seaport Global Securities Buy → Neutral $30
Jan-20-16Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-06-16Initiated Scotia Howard Weil Sector Outperform $31
Nov-03-15Reiterated Argus Buy $44 → $38
Jul-31-15Reiterated Stifel Buy $38 → $34
Jul-23-15Initiated DA Davidson Buy $36
Jun-16-15Initiated Sun Trust Rbsn Humphrey Buy
May-19-15Initiated Wunderlich Buy $38
May-19-15Initiated Deutsche Bank Buy $38
Jan-20-15Reiterated Oppenheimer Outperform $44 → $39
Jun-03-14Initiated Global Hunter Securities Buy $83
May-02-14Reiterated Stifel Buy $75 → $78
May-02-14Reiterated RBC Capital Mkts Outperform $71 → $80
Feb-27-17 08:00AM  Enterprise Products Partners to Participate in Investor Conferences Business Wire
Feb-24-17 01:10PM  2016 K-1 Tax Packages for Enterprise Products Partners L.P. Business Wire
11:05AM  ENTERPRISE PRODUCTS PARTNERS L P Files SEC form 10-K, Annual Report
10:09AM  Enterprise Products Partners L.P. 2016 Form 10-K Now Available Business Wire
Feb-23-17 04:15PM  Enterprise Signs Natural Gas Processing Agreements with Producers from Wyomings Green River Basin Business Wire
10:41AM  Energy Transfer says Dakota Access pipeline 99 pct complete Reuters
Feb-22-17 10:06AM  3 Value Stocks Senior Citizens Could Buy Right Now at Motley Fool
09:06AM  79% of Analysts Recommend a Hold for ONEOK
08:24AM  Analyzing US Crude Oil Movement by Rail in November 2016
Feb-21-17 05:23PM  ETEs Implied Volatility Rises ahead of Its Earnings
01:50PM  Houston co. calls for commitments on new pipeline project at bizjournals.com
10:35AM  Is Kinder Morgan Attractively Valued?
Feb-17-17 03:00AM  Houston midstream companies poised for growth on industry optimism at bizjournals.com
Feb-16-17 12:35PM  Will Targa Resources Increase Its Dividend in 2017?
Feb-12-17 10:20AM  Despite Record Market Highs, Insider Buying Jumps: Walgreens, Arconic, Qualcomm, Enterprise Products Partners and More
03:02AM  Insider Buys Highlight for Week of Feb. 6
Feb-10-17 09:07AM  Will Targa Resources Stock Generate High Returns in 2017?
Feb-08-17 10:38AM  How Have Enbridge Energy Partners Price Targets Changed?
Feb-07-17 06:37PM  Enterprise Products Maintains Upward Momentum at Investopedia
10:28AM  NGL Energys Implied Volatility Rose before Its Earnings Results
08:15AM  Post Earnings Coverage as Hess Reported Better Than Expected Results Accesswire
Feb-04-17 11:46AM  1 Energy Stock With a Better Dividend Than Helmerich & Payne, Inc. at Motley Fool
Feb-03-17 10:45AM  Magellan Midstreams Distributable Cash Flow Rose 8% in 4Q16
Feb-02-17 02:35PM  Plains All Americans Segments: Gauging 4Q16 Performance
01:07PM  ETFs with exposure to Enterprise Products Partners LP : February 2, 2017
12:55PM  Plains All Americans 4Q16 Earnings: Behind the Expectations
12:46PM  Enterprise says Seaway pipeline to resume service by Feb. 7
10:53AM  2 Stocks With Better Dividends Than Kinder Morgan, Inc. at Motley Fool
10:15AM  Enterprise Products Partners Management Sees Some Bright Times Ahead in 2017 at Motley Fool
Feb-01-17 04:43PM  Enterprise Products Partners Is Steady as She Goes
01:39PM  Enterprise Products Partners LP :EPD-US: Earnings Analysis: Q4, 2016 By the Numbers : February 1, 2017
12:15PM  [$$] Ruptured U.S. Oil Pipeline May Restart In 'A Few' Days at The Wall Street Journal
11:00AM  Enterprise Products Partners Has a Solid Business
08:20AM  Enterprise Products Partners (EPD) Misses on Q4 Earnings
Jan-31-17 03:35PM  Analysts Are Still Bullish on Enterprise Products Partners
02:05PM  What Drove Enterprise Products Partners 4Q16 Earnings Growth?
12:32PM  Enterprise Products Partners LP :EPD-US: Earnings Analysis: 2016 By the Numbers : January 31, 2017
12:25PM  Enterprise Products Reports 1.5% Rise in Its 4Q16 EBITDA
11:46AM  Whats behind EnLink Midstreams High Implied Volatility?
11:43AM  [$$] Shutdown of Texas Pipeline Boosting Oil Prices at The Wall Street Journal
09:17AM  Decoding US Crude Oil Movement by Rail in October 2016
08:43AM  [$$] Texas Pipeline, Highway Remain Shut After Rupture at The Wall Street Journal
08:28AM  Enterprise Products Partners' Earnings Showed It Kept the Ship Steady Throughout 2016 at Motley Fool
Jan-30-17 09:35PM  Enterprise Products Partners to expand Permian pipeline by 50 percent at bizjournals.com
03:44PM  Edited Transcript of EPD earnings conference call or presentation 30-Jan-17 3:00pm GMT
12:37PM  Top 5 Oil Stocks for 2017 at Investopedia
10:00AM  Enterprise Products Partners LP Earnings Call scheduled for 10:00 am ET today
07:07AM  Q4 2016 Enterprise Products Partners LP Earnings Release - Before Market Open
06:12AM  Enterprise Products misses 4Q profit forecasts
06:05AM  Enterprise to Build Isobutane Dehydrogenation Unit Business Wire
06:00AM  Enterprise Reports 2016 Results Business Wire
Jan-28-17 01:26PM  3 High-Yield Dividend Stocks to Buy in February at Motley Fool
06:23AM  Earnings, Not Politics, Are Still Driving This Market: Cramer's 'Mad Money' Recap (Friday 1/27/17)
Jan-27-17 08:32AM  Should You Buy Enterprise Products Partners (EPD) Ahead of Earnings?
08:05AM  What's in Store for Exxon Mobil (XOM) this Earnings Season?
Jan-26-17 03:45PM  Enterprise Products Breaks Out Before Ex-Dividend Day at Investopedia
07:38AM  63% of Analysts Call Magellan a Buy ahead of Its 4Q16 Results
07:36AM  How Analysts Rate Enterprise Products ahead of Its 4Q16 Earnings
Jan-25-17 10:36AM  What Does Enterprise Products Partnerss Leverage Indicate?
10:19AM  Enterprise Products (EPD) Q4 Earnings: Is a Beat in Store?
09:07AM  What Could Drive Enterprise Products Partnerss Growth?
07:37AM  Could 4Q16 Results Impact Enterprise Products Partners Stock?
Jan-24-17 10:38AM  Falling Contribution of Gas Gathering, Processing to EPDs Income
09:07AM  How Are EPDs Segments Expected to Perform in 4Q16?
07:39AM  Enterprise Products Is Expected to Report Higher 4Q16 Earnings
Jan-20-17 09:30AM  The Zacks Analyst Blog Highlights: Hess, RPC, Chevron, Anadarko Petroleum and Enterprise Products Partners
Jan-19-17 09:45AM  Plains All American to boost capacity on Permian Basin to Corpus Christi pipeline at bizjournals.com
Jan-18-17 07:47PM  Cramer: The yield on this stock could go down on disappointing Kinder Morgan numbers at CNBC
05:20PM  Tech, Energy and Financial Stocks Are Set to Reap Highest Returns for Investors in 2017
03:35PM  Williams Partners Got Upgrade after Financial Repositioning
Jan-17-17 10:48AM  Which Midstream Stocks Have the Highest Implied Volatility?
Jan-13-17 08:54AM  Why You Should (and Shouldn't) Buy Enterprise Products Partners L.P. at Motley Fool
Jan-10-17 03:38PM  Williams Announces Major Financial Repositioning
10:37AM  What Are Analysts Recommending for Enbridge?
10:19AM  Rice Midstream Sees a Sudden Rise in Implied Volatility
Jan-09-17 01:17PM  Will Kinder Morgan Report Higher 4Q16 Earnings?
12:21PM  Is Enterprise Products Setting Up for a Breakout? at Investopedia
10:38AM  DCP Midstream Partners to Become US Largest NGLs Producer
10:37AM  Which MLPs Look Attractive for 2017?
09:06AM  How Does TC PipeLines Valuation Compare to Its Peers?
08:55AM  Enterprise Products Partners to Participate in UBS MLP One-on-One Conference Business Wire
07:36AM  Why Institutional Investors Seem Bullish on MLPs in 2017
Jan-08-17 09:25AM  3 Oil Stocks to Buy in January at Motley Fool
08:11AM  Top Oil Stocks to Buy in 2017 at Motley Fool
08:04AM  Top Gas Stocks to Buy in 2017 at Motley Fool
Jan-06-17 02:35PM  High Leverage Remained a Concern for MLPs in 2016
10:55AM  7 Dividend Stocks to Put on Your Shopping List at Motley Fool
09:09AM  Enterprise Products (EPD) Hikes Quarterly Distribution
07:45AM  7 MLP Giants That Keep Raising Distributions, Even Through Recent Hard Times
Jan-05-17 04:30PM  DryShips Inc.'s Stock Got Absolutely Pulverized in 2016, But the Worst May Be Over at Motley Fool
08:54AM  Enterprise Declares Quarterly Distribution Increase Business Wire
Jan-04-17 02:36PM  Kelley: Still deals to be made in oil sector
11:42AM  Why High Implied Volatility Midstream Stocks Move More Sharply
06:31AM  Tax repatriation favors mid-cap stocks: Pro
Jan-03-17 10:05AM  Stifel Select List Energy MLPs to Buy for 2017
Dec-30-16 10:35AM  How Does Shell Midstream Partnerss Valuation Compare with Its Peers?
07:38AM  Could ETE Further Simplify Its Organizational Structure in 2017?
Dec-28-16 07:35AM  How Many Analysts Are Rating Enterprise Products Partners a Buy?
Dec-27-16 02:43PM  Summit Midstream Partners Is RBC Capitals Top Pick for 2017
12:06PM  Bullish and Bearish Reversals in the Market
Enterprise Products Partners L.P., a master limited partnership, provides midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals, and refined products. The company operates through NGL Pipelines & Services, Crude Oil Pipelines & Services, Natural Gas Pipelines & Services, and Petrochemical & Refined Products Services segments. The NGL Pipelines & Services segment provides natural gas processing and related NGL marketing services, as well as NGL export docks and related services. It operates approximately 19,500 miles of NGL pipelines; NGL and related product storage facilities; 15 NGL fractionators; and a liquefied petroleum gas export terminal and NGL import facility. The Crude Oil Pipelines & Services segment operates approximately 5,400 miles of crude oil pipelines and related operations; and crude oil storage and marine terminals located in Oklahoma and Texas, as well as a fleet of 478 tractor-trailer tank trucks used to transport crude oil. It also engages in crude oil marketing activities. The Natural Gas Pipelines & Services segment operates approximately 19,100 miles of natural gas pipeline systems to gather and transport natural gas in Colorado, Louisiana, New Mexico, Texas, and Wyoming. It leases underground salt dome natural gas storage facilities in Texas and Louisiana; owns an underground salt dome storage cavern in Texas; and markets natural gas. The Petrochemical & Refined Products Services segment operates propylene fractionation and related operations, including 674 miles of pipelines; butane isomerization complex, associated deisobutanizer units, and related pipeline assets; and octane enhancement and high purity isobutylene production facilities. It also operates refined products pipelines of approximately 4,200 miles; and terminals, as well as provides refined products marketing and marine transportation services. The company was founded in 1968 and is based in Houston, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HACKETT JAMES TDirectorFeb 03Buy28.6533,000945,45033,000Feb 06 04:14 PM
BARTH CARIN MARCYDirectorNov 16Buy25.274,000101,08013,126Nov 16 04:50 PM
VRX Valeant Pharmaceuticals International, Inc. daily Stock Chart
VRX [NYSE]
Valeant Pharmaceuticals International, Inc.
Index- P/E- EPS (ttm)-6.49 Insider Own2.30% Shs Outstand349.87M Perf Week4.18%
Market Cap5.85B Forward P/E3.48 EPS next Y4.81 Insider Trans-30.14% Shs Float332.27M Perf Month22.69%
Income-2256.30M PEG- EPS next Q1.21 Inst Own66.80% Short Float10.72% Perf Quarter-1.36%
Sales10.01B P/S0.58 EPS this Y-133.00% Inst Trans20.06% Short Ratio2.47 Perf Half Y-46.25%
Book/sh11.92 P/B1.40 EPS next Y-11.59% ROA-4.70% Target Price22.39 Perf Year-79.28%
Cash/sh1.88 P/C8.88 EPS next 5Y9.00% ROE-42.90% 52W Range13.00 - 86.50 Perf YTD15.08%
Dividend- P/FCF15.06 EPS past 5Y4.40% ROI3.70% 52W High-80.68% Beta-0.12
Dividend %- Quick Ratio1.10 Sales past 5Y54.60% Gross Margin73.80% 52W Low28.54% ATR0.63
Employees22000 Current Ratio1.50 Sales Q/Q-11.00% Oper. Margin-5.20% RSI (14)64.50 Volatility3.56% 4.13%
OptionableYes Debt/Eq7.31 EPS Q/Q- Profit Margin-22.50% Rel Volume1.17 Prev Close16.18
ShortableYes LT Debt/Eq7.29 EarningsFeb 28 BMO Payout- Avg Volume14.43M Price16.71
Recom3.00 SMA2010.70% SMA5012.53% SMA200-21.65% Volume16,844,758 Change3.28%
Feb-27-17Reiterated Mizuho Underperform $11 → $9
Feb-14-17Reiterated RBC Capital Mkts Sector Perform $29 → $22
Feb-10-17Reiterated Barclays Equal Weight $34 → $20
Jan-04-17Reiterated Piper Jaffray Underweight $16 → $11
Dec-15-16Downgrade Morgan Stanley Overweight → Equal-Weight $25 → $17
Nov-23-16Downgrade Mizuho Neutral → Underperform $25 → $11
Nov-14-16Reiterated Deutsche Bank Hold $29 → $24
Nov-10-16Reiterated Morgan Stanley Overweight $42 → $25
Nov-10-16Downgrade Rodman & Renshaw Buy → Neutral $81 → $23
Nov-09-16Reiterated RBC Capital Mkts Sector Perform $35 → $29
Oct-14-16Reiterated Deutsche Bank Hold $30 → $29
Oct-12-16Reiterated RBC Capital Mkts Sector Perform $36 → $35
Sep-20-16Resumed Deutsche Bank Hold $30
Aug-17-16Upgrade Morgan Stanley Equal-Weight → Overweight $33 → $42
Aug-15-16Upgrade Mizuho Underperform → Neutral $11 → $25
Aug-10-16Reiterated RBC Capital Mkts Sector Perform $31 → $36
Aug-10-16Reiterated Piper Jaffray Underweight $19 → $22
Aug-09-16Reiterated Rodman & Renshaw Buy $90 → $81
Jun-23-16Downgrade JP Morgan Overweight → Neutral
Jun-08-16Reiterated Stifel Buy $65 → $55
Feb-27-17 05:05PM  The Only Number That Matters When Valeant Pharmaceuticals Reports Its Q4 Results at Motley Fool
04:26PM  A quick reminder that Bill Ackman's worst nightmare is still very much a thing
03:29PM  5 Stocks to Watch Before the Market Opens Tomorrow
01:32PM  Why Valeant Might Beat Earnings Expectationsand Why It Won't Matter at Barrons.com
01:23PM  Jim Cramer Is Passing on Valeant Ahead of Earnings
01:14PM  5 Earnings Short-Squeeze Plays to Boost Your Returns
11:07AM  Valeant Ups Sales Force Ahead of Q4 Results at Investopedia
10:19AM  Valeant Pharmaceuticals Stock Climbs Ahead of Earnings Release
10:05AM  Why Valeant is Flying on the Eve of Earnings at Barrons.com
09:12AM  Valeant's High Debt Load Puts Q4 Focus On EBITDA Guidance
08:00AM  Valeant Pharmaceuticals: Overvaluation Situation at Investopedia
07:13AM  Valeant sub Salix hired 250 employees to bolster its GI commitment at MarketWatch
07:00AM  Valeant Announces Deployment Of Expanded Salix Sales Force To Capture Untapped Market Opportunity PR Newswire
07:00AM  Valeant Announces Deployment Of Expanded Salix Sales Force To Capture Untapped Market Opportunity CNW Group
01:51AM  Facing Criticism, Drug Makers Keep Lid On Price Increases at The Wall Street Journal
01:30AM  Bausch + Lomb And Nicox Resubmit US New Drug Application For Novel Glaucoma Candidate Latanoprostene Bunod PR Newswire
01:30AM  Bausch + Lomb And Nicox Resubmit US New Drug Application For Novel Glaucoma Candidate Latanoprostene Bunod CNW Group
Feb-26-17 08:03PM  Drug Companies Keep Lid on Price Increases at The Wall Street Journal
Feb-25-17 10:25AM  Top Biopharma Movers of the Past Week
Feb-24-17 01:29PM  Sequoia Fund wins dismissal of lawsuit over huge Valeant stake
10:47AM  Valeant's Ugly Earnings History May Repeat Itself at Barrons.com
07:58AM  The Demise Of The Erectile Dysfunction TV Ads at Forbes
Feb-23-17 11:43AM  Former Valeant and Philidor executives plead not guilty in fraud scheme Reuters
11:28AM  Former Valeant and Philidor execs plead not guilty in fraud scheme Reuters
11:07AM  Did 50 Salespeople Leave Valeant? Wells Fargo Investigates at Barrons.com
07:00AM  Obagi Medical Products Announces Collaboration With Suzan Obagi, M.D., And Nextcell Medical To Introduce New Line Of Products PR Newswire
07:00AM  Obagi Medical Products Announces Collaboration With Suzan Obagi, M.D., And Nextcell Medical To Introduce New Line Of Products CNW Group
02:08AM  PRESS DIGEST- New York Times business news - Feb 23 Reuters
Feb-21-17 05:25PM  Tiny Waltham biotech's market cap doubles after $103M Valeant licensing deal at bizjournals.com
03:57PM  Valeant Acquires Eyegate Licensing Rights
11:10AM  Tuesdays Top Biopharma Movers
09:30AM  The Zacks Analyst Blog Highlights: Merck, Valeant Pharmaceuticals International, Allergan, AstraZeneca and Johnson & Johnson
07:44AM  EyeGate Pharma surges 15% on news of Valeant licensing agreement at MarketWatch
07:44AM  EyeGate Pharma surges 15% on news of Valeant licensing agreement
07:30AM  Valeant Pharmaceuticals And EyeGate Enter Into Licensing Agreement For EGP-437 Combination Product In Post-Operative Pain And Inflammation In Ocular Surgery Patients PR Newswire
07:30AM  Valeant Pharmaceuticals And EyeGate Enter Into Licensing Agreement For EGP-437 Combination Product In Post-Operative Pain And Inflammation In Ocular Surgery Patients CNW Group
Feb-20-17 03:40PM  This Guru Loves Valeant; Should You?
01:33PM  [$$] Unilever was a deal too far for Kraft Heinz at Financial Times
Feb-19-17 06:00AM  Sequoia's Foundation Looks Stronger Than It Was Before at Morningstar
Feb-17-17 09:12AM  Valeant's (VRX) Plaque Psoriasis Drug Approved in the U.S.
09:09AM  It Happened Again! Another Drugmaker Got Caught With an Exorbitant Price Hike at Motley Fool
08:05AM  AstraZeneca Stock Rises On Successful Breast Cancer Drug Trial
Feb-16-17 04:41PM  Don't Count on Valeant's New Drug to Save the Day at Motley Fool
01:55PM  Francis Chou Adds to Valeant, Trims Sears in 4th Quarter
01:43PM  Billionaire Bill Ackmans Pershing Square Boosts Bet on Fast Food Industry, Cuts Down on Healthcare at Insider Monkey
12:05PM  Why This FDA Approval for Valeant Is Not as Good as First Thought
11:54AM  New Valeant Approval is a Surprise Irritant at The Wall Street Journal
10:38AM  Valeant Pharmaceuticals: Dead in the Water? at Barrons.com
10:04AM  Stocks to Watch: Kate Spade, MGM Resorts, Avon Products at The Wall Street Journal
09:03AM  Morning Movers: Valeant Jumps, Kate Spade Soars, MGM Drops at Barrons.com
07:22AM  Valeant stock surges 3% after psoriasis drug gets FDA approval at MarketWatch
07:00AM  Valeant Receives FDA Approval Of SILIQ (Brodalumab) For Moderate-To-Severe Plaque Psoriasis PR Newswire
07:00AM  Valeant Receives FDA Approval Of SILIQ (Brodalumab) For Moderate-To-Severe Plaque Psoriasis CNW Group
Feb-15-17 06:37PM  Bill Ackman Expands Chipotle Position, Cuts Zoetis +5.51%
06:34PM  FDA approves Valeant's drug to treat plaque psoriasis Reuters
10:49AM  These 3 Hedge Funds Are Playing With Fire at Motley Fool
10:42AM  Eli Lilly Is Great Stock to Buy Now
Feb-14-17 05:24PM  Ackman boosted Chipotle holdings, pared Valeant in 4th quarter at MarketWatch +6.75%
10:39AM  Valeant: Why $3.75 Billion is the Most Important Number at Barrons.com
09:24AM  Valeant, Pershing Square to Split Legal Fees on Allergan Lawsuit
Feb-13-17 05:00PM  Valeant Pharmaceuticals To Participate At Healthcare Conferences PR Newswire
05:00PM  Valeant Pharmaceuticals To Participate At Healthcare Conferences CNW Group
04:34PM  VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Feb-10-17 01:58PM  Valeant Pharmaceutcials: I Guess That's Why They Call It 'Equal Weight' at Barrons.com
Feb-09-17 10:49AM  The Important Lesson We Can All Learn From Valeant Pharmaceuticals at Motley Fool
Feb-08-17 09:59AM  Valeant: Another Analyst Cuts Target, Stays Buy Rated Into Earnings at Barrons.com
07:36AM  What Bill Miller Thinks about Valeant Pharmaceuticals
Feb-07-17 12:20PM  Ruane, Cunniff & Goldfarb's Sequoia Fund 4th Quarter Shareholder Letter
10:07AM  Valeant Pharmaceuticals: Worthy of Your Trust? at Barrons.com
08:24AM  Perrigo says it has filed for FDA approval for a generic version of Valeant's acne gel at MarketWatch
Feb-06-17 11:53AM  Valeant Pharmaceuticals: Why This Earnings Report is Really, Really Important at Barrons.com
06:45AM  Why Valeant Pharmaceuticals' Rebound Fizzled at Motley Fool
Feb-03-17 10:23AM  Merck's Sneak Peek Into Its Drug Pricing May Not Be Enough to Satisfy Skeptics at Motley Fool
Feb-02-17 07:36PM  Valeant Short Seller Picks Next Target
07:36PM  Valeant Short Seller Picks Next Target at Bloomberg
09:50AM  7 Stocks You Should Sell Right Now at Kiplinger
Feb-01-17 09:30AM  The Zacks Analyst Blog Highlights: Synergy Pharmaceuticals, Amgen, Valeant Pharmaceuticals International, Celgene and Lexicon Pharmaceuticals
05:00AM  The Short Seller Who Crushed Valeant Has Picked His Next Target at Bloomberg
Jan-31-17 06:43AM  4 FDA Decisions to Watch Out for in Feb 2017
Jan-30-17 04:30PM  Valeant To Hold Conference Call To Present Fourth Quarter And Full Year 2016 Results And Announce 2017 Guidance PR Newswire
04:30PM  Valeant To Hold Conference Call To Present Fourth Quarter And Full Year 2016 Results And Announce 2017 Guidance CNW Group
01:12PM  Is Valeant Pharmaceuticals' Turnaround Finally in the Cards? at Motley Fool
11:16AM  Valeant Pharmaceuticals: A Challenging Setup? at Barrons.com
Jan-27-17 12:49PM  Pershing Square Defends Valeant's Progress, Can't Defend Its Stock Performance
Jan-26-17 12:27PM  Valeant Stock Rises 5% on Possible Asset Sales at Investopedia
09:30AM  Broadcom, Valeant Pharmaceuticals, Apple, Amazon and Netflix highlighted as Zacks Bull and Bear of the Day Broadcom, Valeant Pharmaceuticals, Apple, Amazon and Netflix highlighted as Zacks Bull and Bear of the Day
07:00AM  Bear of the Day: Valeant Pharmaceuticals (VRX)
Jan-24-17 03:46PM  Options Insight: How to Play Valeant
09:16AM  New Strong Sell Stocks for January 24th
Jan-23-17 02:45PM  Analysts dismiss Citron's sour take on TransDigm -5.02%
Jan-21-17 02:42PM  What Will Valeant Pharmaceuticals Sell Off Next? at Motley Fool
02:20PM  A Fond Farewell
Jan-20-17 03:31PM  Short-Seller Andrew Left Says Trump Should Target This Aerospace Stock
12:12PM  Why TransDigm Stock Tumbled 12% Today at Motley Fool
Jan-18-17 04:27PM  Dealpolitik: SEC Tilts Playing Field Against Targets of Hostile Bids at The Wall Street Journal
Jan-17-17 06:19PM  Short Sellers Now Fleeing Valeant Stock at Investopedia
05:49PM  [$$] Allergan Admits to Disclosure Violations During Valeant Bid at The Wall Street Journal
04:44PM  Bill Ackman Eases Into the New Year at Investopedia
07:37AM  Mario Gabelli on Viacom: Potential Growth in the Media Sector
Jan-13-17 04:39PM  Will This Be a Genius or Foolish Move for Johnson & Johnson? at Motley Fool
Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide. The company offers Xifaxan for the treatment of irritable bowel syndrome with diarrhea; Wellbutrin XL for major depressive disorder in adults; Solodyn to treat red and pus-filled pimples of acne in patients, as well as Ziana, Clindagel, Acanya, Atralin, Retin- A Micro, and ONEXTON gel; Glumetza to improve glycemic control in adults with type 2 diabetes mellitus; PROVENGE for the treatment of prostate cancer; and Jublia for onychomycosis of the toenails. It also provides Nitropress for the immediate reduction of blood pressure of patients in hypertensive crises; Isuprel for heart related treatments; Xenazine for chorea; Uceris to get ulcerative colitis under control; Lotemax gel for post-operative inflammation and pain; Arestin, a subgingival sustained-release antibiotic; PreserVision, an antioxidant eye vitamin and mineral supplement; CeraVe to rebuild and repair the skin barrier; Biotrue for healthy contact lens wear; and ReNu Multiplus to lubricate and rewet soft contact lenses. In addition, the company offers Ocuvite, a lutein eye vitamin and mineral supplement; Boston, a cleansing solution for gas permeable contact lenses; Artelac to treat dry eyes; various ophthalmic surgical products; SofLens daily disposable contact lenses; Biotrue ONEday lens; Bausch + Lomb Ultra, a contact lens PureVision, a contact lens; and medical device systems for aesthetic applications. Further, it provides Tobramycin and Dexamethasone ophthalmic suspension for steroid responsive inflammatory ocular conditions; Metronidazole to treat bacterial infections; and Latanoprost for the treatment of glaucoma. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September, 2010. The company was founded in 1983 and is based in Laval, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ross Thomas W. Sr.DirectorDec 14Buy14.735,00073,65026,822Dec 16 04:19 PM
Pershing Square Capital ManageDirectorDec 12Sale14.853,476,69051,628,84718,114,432Dec 13 04:14 PM
KARABELAS ARGERIS NDirectorAug 11Buy24.654,00098,60020,726Aug 12 04:37 PM
Ross Thomas W. Sr.DirectorJun 13Buy24.404,00097,60021,882Jun 27 03:40 PM
PAPA JOSEPH CCHAIRMAN & CEOJun 10Buy24.48202,0004,944,9602,442,199Jun 13 06:47 AM
LYB LyondellBasell Industries N.V. daily Stock Chart
LYB [NYSE]
LyondellBasell Industries N.V.
IndexS&P 500 P/E10.03 EPS (ttm)9.11 Insider Own3.20% Shs Outstand405.58M Perf Week-1.70%
Market Cap37.04B Forward P/E10.15 EPS next Y9.00 Insider Trans-24.59% Shs Float322.78M Perf Month-4.26%
Income3.84B PEG- EPS next Q2.32 Inst Own76.30% Short Float2.67% Perf Quarter6.46%
Sales29.18B P/S1.27 EPS this Y-4.70% Inst Trans0.62% Short Ratio2.90 Perf Half Y16.84%
Book/sh14.86 P/B6.15 EPS next Y-9.87% ROA16.30% Target Price97.55 Perf Year16.27%
Cash/sh4.99 P/C18.32 EPS next 5Y-2.76% ROE61.90% 52W Range69.14 - 97.64 Perf YTD6.47%
Dividend3.40 P/FCF18.82 EPS past 5Y16.00% ROI24.60% 52W High-6.46% Beta1.04
Dividend %3.72% Quick Ratio1.30 Sales past 5Y-9.50% Gross Margin20.50% 52W Low32.10% ATR1.72
Employees13000 Current Ratio2.10 Sales Q/Q9.60% Oper. Margin17.40% RSI (14)45.44 Volatility1.78% 1.63%
OptionableYes Debt/Eq1.48 EPS Q/Q9.70% Profit Margin13.10% Rel Volume0.90 Prev Close92.43
ShortableYes LT Debt/Eq1.39 EarningsFeb 03 BMO Payout36.60% Avg Volume2.98M Price91.33
Recom2.60 SMA20-2.19% SMA500.58% SMA20011.44% Volume2,675,952 Change-1.19%
Feb-10-17Downgrade Susquehanna Positive → Neutral
Feb-06-17Reiterated RBC Capital Mkts Sector Perform $92 → $95
Dec-29-16Reiterated Cowen Market Perform $87 → $90
Oct-14-16Initiated Tudor Pickering Buy
Sep-13-16Reiterated Deutsche Bank Hold $80 → $83
Jun-27-16Downgrade RBC Capital Mkts Outperform → Sector Perform $100 → $84
Jun-23-16Downgrade JP Morgan Overweight → Neutral $100 → $80
Jun-13-16Downgrade Cowen Outperform → Market Perform $105 → $87
Apr-27-16Downgrade Nomura Buy → Neutral
Apr-05-16Downgrade Atlantic Equities Neutral → Underweight
Feb-03-16Downgrade RBC Capital Mkts Top Pick → Outperform $105 → $95
Jan-11-16Downgrade Credit Agricole Outperform → Underperform
Nov-25-15Reiterated Cowen Outperform $98 → $105
Oct-12-15Downgrade Macquarie Outperform → Neutral
Sep-17-15Reiterated Deutsche Bank Hold $100 → $95
Sep-11-15Initiated Bernstein Outperform $110
Sep-01-15Reiterated Cowen Outperform $115 → $98
May-08-15Initiated Standpoint Research Buy
Apr-28-15Reiterated RBC Capital Mkts Top Pick $111 → $123
Apr-27-15Reiterated Jefferies Hold $85 → $99
Feb-27-17 09:07AM  Why DuPont Is Trading at a Premium Compared to Its Peers
Feb-23-17 05:26PM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
01:04PM  LYONDELLBASELL INDUSTRIES N.V. Financials
Feb-21-17 05:51PM  LyondellBasell Prices Public Offering of Guaranteed Notes PR Newswire
10:33AM  LYB International Finance II B.V. -- Moody's rates LyondellBasell's new notes Baa1, outlook stable at Moody's
Feb-17-17 01:05PM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 10-K, Annual Report
06:45AM  LyondellBasell Board Authorizes Interim Dividend PR Newswire
Feb-14-17 08:15AM  Post Earnings Coverage as LyondellBasell's Q4 Top-line Beat Market Estimates Accesswire
Feb-08-17 09:06AM  How Are Analysts Viewing LyondellBasell after 4Q16 Earnings?
07:36AM  Why LyondellBasells Refining Segment Revenues Rose in 4Q16
Feb-07-17 02:19PM  LyondellBasell Industries NV :LYB-US: Earnings Analysis: 2016 By the Numbers : February 7, 2017
10:40AM  Why Did LYBs Intermediates and Derivatives Segments Revenue Rise?
09:07AM  How Did LYBs EAI Olefins and Polyolefins Segment Perform in 4Q16?
07:36AM  How Did LYBs Olefins and Polyolefins Americas Segment Fare?
Feb-06-17 05:35PM  LyondellBasells 4Q16 Adjusted Earnings Beat Estimates
03:47PM  LyondellBasell Stock Rose after 4Q16 Revenue Beat Estimates
10:59AM  LyondellBasell Industries NV :LYB-US: Earnings Analysis: Q4, 2016 By the Numbers : February 6, 2017
Feb-03-17 04:40PM  Edited Transcript of LYB earnings conference call or presentation 3-Feb-17 4:00pm GMT
02:56PM  LyondellBasell's (LYB) Q4 Earnings, Revenues Top Estimates
08:39AM  LyondellBasell (LYB) Q4 Earnings, Sales Beat Estimates
07:16AM  LyondellBasell tops Street 4Q forecasts
07:07AM  Q4 2016 LyondellBasell Industries NV Earnings Release - Before Market Open
06:45AM  LyondellBasell Reports 2016 Earnings PR Newswire
Feb-02-17 08:34AM  Should You Sell LyondellBasell Industries (LYB) Before Earnings?
06:59AM  FMC Corp (FMC) Q4 Earnings: What's in Store for the Stock?
Feb-01-17 01:30PM  Here's How Valero's Management Thinks Trump's Policies Will Impact the Business at Motley Fool
08:50AM  LyondellBasell (LYB) Q4 Earnings: What's in the Cards?
Jan-30-17 09:30AM  Zacks.com featured highlights: OraSure Technologies, Union Pacific, LyondellBasell Industries, Advanced Energy Industries and Rollins
Jan-27-17 08:32AM  5 Efficient Stocks Potent Enough to Boost Your Returns
Jan-26-17 09:30AM  Zacks Investment Ideas feature highlights: Abb, Applied Materials, Broadcom, LyondellBassel and Union Pacific
09:06AM  Why LyondellBasell Is Trading at a Discount Compared to Peers
07:37AM  Why Most Analysts Recommend a Hold for LyondellBasell
Jan-25-17 02:05PM  Why Analysts Expect 21% Rise in LyondellBasells EPS
12:36PM  Why Analysts Expect LyondellBasells Revenue to Rise in 4Q16
10:58AM  Why LyondellBasell Stock Bounced Back after Disappointing 3Q16
Jan-23-17 02:46PM  8 Stocks Trading Below Peter Lynch Value
01:19PM  LyondellBasell Industries NV : LYB-US: Dividend Analysis : November 29th, 2016 (record date) : By the numbers : January 23, 2017
09:45AM  Is LyondellBasell Industries a Great Stock for Value Investors?
09:06AM  Dow Chemicals Latest Valuations ahead of Its 4Q16 Earnings
09:06AM  A Quick Look at DuPonts Valuation ahead of Its 4Q16 Earnings
Jan-20-17 05:37PM  LyondellBasell to Discuss Fourth-Quarter Results on Friday, February 3, 2017 PR Newswire
03:36PM  7 Price and Earnings Momentum Winners
10:26AM  Will Material ETFs Sustain Their Rally as Q4 Earnings Unfold?
06:57AM  LyondellBasell Wraps Up Corpus Christi Ethylene Expansion
Jan-19-17 10:02AM  Top Ranked Growth Stocks to Buy for January 19th
09:30AM  The Zacks Analyst Blog Highlights: Kronos Worldwide, Ingevity, LyondellBasell Industries NV, Celanese Corporation and Albemarle
06:45AM  LyondellBasell Corpus Christi Complex Expansion Complete PR Newswire
Jan-18-17 05:27PM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements an
05:00PM  LyondellBasell announces planned leadership changes PR Newswire
03:29PM  5 Chemical Growth Stocks to Enrich Your Portfolio in 2017
Jan-13-17 04:06PM  LyondellBasell Donation to Provide Specialized Training for Six Houston-Area Fire Departments PR Newswire
09:11AM  Has DuPonts Stock Performance Retreated?
Jan-10-17 12:10PM  10 Best Stocks for Retired Investors at Kiplinger
08:15AM  Post Earnings Coverage as RPM Sales Up 3%, Earnings Dropped 5.5% Accesswire
Jan-09-17 07:36AM  How Is Dow Chemical Valued Compared to Its Peers?
Jan-06-17 09:07AM  Dow Chemical Stock: The Rapid Surge in December
Jan-05-17 03:50PM  LyondellBasell to keep Houston refinery at bizjournals.com
Jan-04-17 04:36PM  Solvay Has High Ebitda Margins and Is Paying Down Debt
06:49AM  LyondellBasell (LYB) Well Poised on Expansion Actions
Dec-30-16 08:15AM  Blog Coverage PPG Sells the Plaka Business to Knauf Accesswire
Dec-22-16 01:00AM  U.S. refiners cash in on Mexico's record fuel imports Reuters
Dec-21-16 12:35PM  Analyzing Air Products and Chemicalss Dividend Yield and Payout
Dec-19-16 07:36AM  Why Does LyondellBasell Keep Trading at a Discount?
Dec-17-16 05:13PM  How TransCanada Corporation (USA) (TRP) Stacks Up Against Similarly Valued Stocks at Insider Monkey
Dec-16-16 02:05PM  The Word on the Street: What Analysts Are Recommending for LyondellBasell
12:35PM  How Much Has LyondellBasell Been Rewarding Its Shareholders?
10:58AM  Could LyondellBasell Stock Be Making a Comeback?
Dec-13-16 04:42PM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 8-K, Change in Directors or Principal Officers
02:05PM  Heres the Latest from Analysts on Praxair
12:22PM  Why LyondellBasell and Huntsman Jumped More Than 10% in November at Motley Fool
09:00AM  Walmart Launches Online Destination for Last-Minute Shoppers
Dec-07-16 05:11PM  Chemicals Industry Stock Outlook - Dec 2016
09:36AM  Snapshot of Dow Chemicals Growth Opportunity in Saudi Arabia
Dec-03-16 03:03PM  The Best Plastic Stocks to Buy Today at Motley Fool
Nov-29-16 04:13AM  2 chemical stocks to buy and 2 to sell at MarketWatch
02:25AM  LyondellBasell Industries NV (LYB): Are Hedge Funds Right About This Stock? at Insider Monkey
Nov-28-16 01:34PM  Positives and Negatives of LyondellBasells 3Q16 Earnings
07:51AM  4 Blue Chip Stocks to Buy as Trump Rally Rages On
Nov-21-16 01:04PM  LyondellBasell Declares 4Q Dividend of $0.85
Nov-18-16 06:45AM  LyondellBasell Board Authorizes Interim Dividend PR Newswire
Nov-17-16 12:00PM  LyondellBasell to Address Citi's Basic Materials Conference PR Newswire
11:19AM  Polish Basell Orlen declares force majeure on some products
Nov-16-16 11:13AM  Andreas Halvorsen's Top 3 New Holdings
Nov-14-16 01:50PM  Two Chemicals Stocks Expected To Surge Under Trump Administration at Forbes
Nov-08-16 08:04AM  Lower Oil Prices Affect LYBs Refining Segments 3Q16 Earnings
Nov-07-16 04:06PM  A Quick Look at a Few Chemical Companies in 2016
11:04AM  What Do Analysts Think of LyondellBasell after Its 3Q16 Earnings?
10:04AM  How LYBs Intermediates & Derivatives Segment Performed in 3Q16
08:06AM  Why LYBs Olefins & Polyolefins EAI Segment Saw Higher Earnings
Nov-04-16 05:04PM  How LYBs Olefins & Polyolefins Americas Segment Did in 3Q16
03:04PM  Why Did LyondellBasells 3Q16 Earnings Miss Estimates?
01:13PM  Planned Maintenance Continues to Weigh Heavily on LyondellBasell
Nov-03-16 12:15PM  ETFs with exposure to LyondellBasell Industries NV : November 3, 2016
Nov-02-16 06:00PM  LyondellBasell to Address Morgan Stanley Global Chemicals and Agriculture Conference PR Newswire
09:44AM  LyondellBasell Industries NV :LYB-US: Earnings Analysis: Q3, 2016 By the Numbers : November 2, 2016
08:33AM  LyondellBasell Industries NV breached its 50 day moving average in a Bearish Manner : LYB-US : November 2, 2016
Nov-01-16 06:40PM  Edited Transcript of LYB earnings conference call or presentation 1-Nov-16 3:00pm GMT
11:04AM  Why Did DuPonts Electronics and Communications Segment Revenue Decline in 3Q16?
11:02AM  [$$] LyondellBasell Results Hurt by Operating Disruptions at The Wall Street Journal
10:12AM  LyondellBasell (LYB) Beats on Q3 Earnings and Revenues
LyondellBasell Industries N.V. operates as a manufacturer of chemicals and polymers, refiner of crude oil, producer of gasoline blending components, and developer and licensor of technologies for production of polymers worldwide. The company operates in five segments: Olefins and PolyolefinsAmericas; Olefins and PolyolefinsEurope, Asia, International; Intermediates and Derivatives; Refining; and Technology. It produces and markets olefins, including ethylene, propylene, and butadiene; polyethylene products, which consist of high density polyethylene, low density polyethylene, and linear low density polyethylene; polyolefins, such as polyethylene and polypropylene (PP); and PP homopolymers, copolymers, and compounds. The company also produces and sells propylene oxide and its derivatives; oxyfuels and related products; and intermediate chemicals, such as styrene monomers, methanol products, glacial acetic acids, vinyl acetate monomers, and ethylene oxides and derivatives. In addition, it refines crude oil into gasoline, diesel, and jet fuel; develops and licenses chemical and polyolefin process technologies; and manufactures and sells polyolefin catalysts, as well as purchases and sells ethylene. The company also exports its products. LyondellBasell Industries N.V. was founded in 2005 and is based in London, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wolf Jacquelyn HSVP, Human ResourcesFeb 22Option Exercise78.2714,7691,155,95931,283Feb 22 08:13 PM
Wolf Jacquelyn HSVP, Human ResourcesFeb 22Sale94.0114,7691,388,41616,514Feb 22 08:13 PM
AI New Holdings 2 LLC10% OwnerFeb 22Sale94.5514,1711,339,85873,157Feb 24 04:04 PM
AI New Holdings 2 LLC10% OwnerFeb 13Sale92.24862,20579,532,80773,171Feb 14 05:51 PM
AI New Holdings 2 LLC10% OwnerFeb 10Sale92.45305,70028,261,84374,030Feb 14 05:51 PM
AI New Holdings 2 LLC10% OwnerFeb 09Sale92.29900,00083,056,95074,334Feb 09 06:11 PM
AI New Holdings 2 LLC10% OwnerFeb 08Sale91.591,132,095103,689,48775,231Feb 09 06:11 PM
AI New Holdings 2 LLC10% OwnerFeb 07Sale93.021,000,00093,018,14776,359Feb 09 06:11 PM
Bindra Jagjeet S.DirectorAug 30Sale80.013,750300,0208,876Sep 01 09:17 AM
Covezzi MassimoSVP Research & DevelopmentApr 26Sale89.147,551673,1119,702Apr 26 04:28 PM
Vasnetsov SergeySVP Strategic PlanningApr 26Sale89.893,127281,0764,733Apr 26 04:28 PM
AI INTERNATIONAL CHEMICALS S.A10% OwnerMar 09Sale82.531,100,00090,786,41077,354Mar 10 04:38 PM
AI INTERNATIONAL CHEMICALS S.A10% OwnerMar 08Sale82.041,000,00082,042,77779,646Mar 10 04:38 PM
TMO Thermo Fisher Scientific Inc. daily Stock Chart
TMO [NYSE]
Thermo Fisher Scientific Inc.
IndexS&P 500 P/E31.09 EPS (ttm)5.10 Insider Own0.10% Shs Outstand394.40M Perf Week-0.10%
Market Cap62.50B Forward P/E15.70 EPS next Y10.10 Insider Trans-14.60% Shs Float393.75M Perf Month10.75%
Income2.03B PEG2.94 EPS next Q2.02 Inst Own88.70% Short Float1.21% Perf Quarter10.55%
Sales18.27B P/S3.42 EPS this Y3.40% Inst Trans-0.95% Short Ratio2.50 Perf Half Y4.93%
Book/sh54.59 P/B2.90 EPS next Y10.23% ROA4.50% Target Price172.79 Perf Year21.75%
Cash/sh- P/C- EPS next 5Y10.56% ROE9.50% 52W Range128.55 - 160.35 Perf YTD12.32%
Dividend0.60 P/FCF25.27 EPS past 5Y13.90% ROI6.40% 52W High-1.17% Beta1.09
Dividend %0.38% Quick Ratio1.00 Sales past 5Y9.60% Gross Margin46.50% 52W Low23.29% ATR2.03
Employees52000 Current Ratio1.50 Sales Q/Q6.50% Oper. Margin13.40% RSI (14)71.68 Volatility0.88% 1.38%
OptionableYes Debt/Eq0.77 EPS Q/Q5.80% Profit Margin11.10% Rel Volume0.64 Prev Close158.98
ShortableYes LT Debt/Eq0.71 EarningsJan 31 BMO Payout11.70% Avg Volume1.91M Price158.48
Recom1.70 SMA202.64% SMA507.11% SMA2005.50% Volume1,220,207 Change-0.31%
Jan-18-17Initiated Deutsche Bank Buy $163
Nov-10-16Resumed Leerink Partners Outperform
Sep-22-16Resumed JP Morgan Overweight $180
Sep-09-16Downgrade Cleveland Research Buy → Neutral
May-27-16Reiterated Mizuho Buy $166 → $170
May-19-16Reiterated Mizuho Buy $163 → $166
May-03-16Reiterated Mizuho Buy $160 → $163
Apr-29-16Downgrade Jefferies Buy → Hold
Apr-04-16Reiterated Mizuho Buy $150 → $160
Mar-02-16Reiterated Topeka Capital Markets Buy $145 → $155
Jan-11-16Reiterated Stifel Buy $150 → $158
Jan-07-16Initiated Deutsche Bank Buy $160
Oct-06-15Initiated Argus Buy $145
Jul-23-15Reiterated Mizuho Buy $150 → $160
May-21-15Reiterated Barclays Overweight $160 → $165
Mar-10-15Initiated UBS Buy $160
Jan-21-15Reiterated Robert W. Baird Outperform $142 → $144
Aug-12-14Initiated Stifel Buy $150
Jan-30-14Reiterated Mizuho Buy $130 → $140
Jan-30-14Reiterated ISI Group Buy $121.50 → $130
Feb-26-17 09:25PM  Two Mass. companies involved in some of the biggest tech M&A deals of 2016 at bizjournals.com
Feb-24-17 09:11AM  Patent Damages In The Global Supply Chain at Forbes
Feb-22-17 01:10PM  Thermo Fisher unit prevails in Supreme Court patent case at bizjournals.com
10:25AM  Thermo Fisher Comes Out on Top in Promega Patent Case
10:13AM  Thermo Fisher did not infringe genetic-testing patent, U.S. top court says Reuters
10:11AM  Thermo Fisher Backed by Supreme Court in Promega Patent Case
10:11AM  Patent Royalties Curbed as Supreme Court Backs Thermo Fisher
Feb-14-17 06:15PM  Thermo Fisher Scientific Completes Acquisition of Finesse Solutions, Inc. Business Wire
Feb-13-17 09:15AM  Thermo Fisher Scientific Receives Early Termination of Hart-Scott-Rodino Waiting Period for Acquisition of Finesse Solutions, Inc. Business Wire
Feb-08-17 04:53PM  Better Buy: Illumina, Inc. vs. Thermo Fisher Scientific at Motley Fool
Feb-07-17 08:57AM  Weitz Investment Looks to Visa (V), Amazon (AMZN), Others for Big Returns After Subpar 2016 at Insider Monkey
Feb-02-17 03:10PM  Why the state's two biggest medical device firms have gained $4.5B in market cap this week at bizjournals.com
09:30AM  The Zacks Analyst Blog Highlights: Johnson & Johnson, PayPal, Thermo Fisher, Celgene and American Airlines
Feb-01-17 05:59PM  Final Trade: DIS, GOOGL & more
03:17PM  Top Research Reports for February 1, 2017
Jan-31-17 06:30PM  Why Momenta Pharmaceuticals, Ally Financial, and Thermo Fisher Scientific Jumped Today at Motley Fool +6.35%
04:55PM  The Hot Stock: Thermo Fisher Scientific Jumps 6.4% at Barrons.com
04:37PM  Edited Transcript of TMO earnings conference call or presentation 31-Jan-17 1:30pm GMT
03:19PM  Thermo Fisher Scientific, Inc. : TMO-US: Dividend Analysis : December 15th, 2016 (record date) : By the numbers : January 31, 2017
02:19PM  Thermo Fisher CEO Says M&A Funnel Is 'Pretty Full'
08:58AM  Thermo Fisher (TMO) Q4 Earnings Beat, Organic Sales Flat
07:42AM  Thermo Fisher (TMO): Tops Q4 Earnings, Misses Revenues
07:07AM  Q4 2016 Thermo Fisher Scientific Inc Earnings Release - Before Market Open
06:26AM  Thermo Fisher beats 4Q profit forecasts
06:02AM  Thermo Fisher quarterly profit tops Wall Street expectations
06:00AM  Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2016 Results Business Wire
Jan-30-17 07:25AM  Thermo Fisher Scientific, Inc. breached its 50 day moving average in a Bullish Manner : TMO-US : January 30, 2017
07:06AM  Medical Products Stocks' Earnings on Jan 31: ZBH, TMO, ABC
Jan-26-17 03:17PM  Weitz Funds Comments on Thermo Fisher Scientific
Jan-20-17 04:56PM  John Rogers Comments on Thermo Fisher Scientific Inc.
06:05AM  How a Thermo Fisher employee spurred Mass. biotechs to fight homelessness at bizjournals.com
Jan-19-17 08:34AM  Thermo Fisher Scientific, Inc. breached its 50 day moving average in a Bearish Manner : TMO-US : January 19, 2017
Jan-18-17 03:54PM  Coverage initiated on Thermo Fisher by Deutsche Bank
07:40AM  Will Thermo Fisher (TMO) Beat Earnings Estimates in Q4?
Jan-13-17 04:02PM  Santoli: Market's been hard to rattle, but also hard to i...
10:38AM  Behind Johnson & Johnsons Recent Stock Performance
Jan-12-17 05:10PM  Trumps HHS nominee has promised to divest from these Mass. companies at bizjournals.com
Jan-06-17 11:05AM  Thermo Fisher Scientific, Inc. Value Analysis (NYSE:TMO) : January 6, 2017
09:00AM  Thermo Fisher Scientific to Hold Earnings Conference Call on Tuesday, January 31, 2017 Business Wire
Jan-05-17 08:24AM  Thermo Fisher Scientific, Inc. breached its 50 day moving average in a Bullish Manner : TMO-US : January 5, 2017
Jan-04-17 06:05PM  Roberts recuses from patent case after discovering conflict
05:49PM  U.S. chief justice steps aside in patent case over stock conflict Reuters
Jan-03-17 08:30AM  Thermo Fisher Scientific to Present at 35th Annual J.P. Morgan Healthcare Conference on January 10, 2017 Business Wire
Jan-02-17 10:37AM  BD Lifesciencess Product Pipeline Could Boost Its Fiscal 2017 Growth
09:07AM  BD Lifesciencess Performance and Core Focus Areas
Dec-16-16 12:56PM  Billionaire Larry Robbins Knows How To Pick Mega-Cap Stocks at Insider Monkey
Dec-14-16 04:08PM  THERMO FISHER SCIENTIFIC INC. Files SEC form 8-K, Change in Directors or Principal Officers
11:08AM  Illumina Stock Now Worth a Lot Less? Here's What You Need to Know at Motley Fool
Dec-13-16 09:30AM  Zacks.com featured highlights: Arch Capital Group, NICE, First American Financial, Silicon Motion Technology and Thermo Fisher Scientific
Dec-12-16 07:23AM  5 GARP Stocks that Should Grace Your Portfolio
Dec-07-16 11:18AM  A Quick Review of Thermo Fisher
Dec-06-16 04:35PM  Cryder Capital Boosts Bets On Alphabet (GOOG), Credit Cards, Health Stocks at Insider Monkey
07:20AM  Supreme Court case involving Thermo Fisher could affect big manufacturers at bizjournals.com
Dec-03-16 07:43PM  5 Capital Goods Stocks Hedge Funds Were Dumping in Q3 at Insider Monkey
Dec-02-16 02:46PM  MedTech Sails Through Macro Woes: Stocks in Focus
08:05AM  Boston Scientific Completes Its Acquisition of EndoChoice
Dec-01-16 10:05AM  Baxter Makes Significant Advancements in Hemodialysis Treatments
08:05AM  How Baxter Continues to Contribute to Patient Care
Nov-30-16 05:02PM  A Growth Stock in the Land of Value Stocks?
10:48AM  What Are Analysts Recommendations for Thermo Fisher Scientific?
10:48AM  TMO Creates Shareholder Value through Strong Capital Allocation
10:48AM  How Is Thermo Fisher Scientifics FEI Integration Process Going?
10:48AM  How Is Thermo Fisher Scientific Accelerating Growth?
10:48AM  How Has Thermo Fisher Scientifics Stock Performed Recently?
Nov-28-16 02:57PM  Battle of Bulls and Bears Lies Ahead for Thermo Fisher
09:30AM  Zacks.com featured highlights: First American Financial, AngioDynamics, Microsemi, Thermo Fisher Scientific and F5 Networks
07:41AM  Is Thermo Fisher Scientific Inc. (TMO) a Good Stock to Invest in? at Insider Monkey
Nov-25-16 08:18AM  5 GARP Stocks to Benefit from Trump Induced Rebound
Nov-23-16 12:21PM  Eli Lilly & Juno Therapeutics plummet after failed drug t...
Nov-21-16 11:04AM  Exploring the Nuances of Strykers Cost Transformation for Growth
10:04AM  How Is Stryker Moving Forward with International Growth?
08:04AM  How Are Strykers Core Strategies Working Toward Its Growth?
Nov-18-16 04:37PM  What Are Analysts Latest Recommendations for Stryker?
Nov-15-16 09:31AM  Thermo Fisher Scientific Inc. (TMO), HCA Holdings Inc (HCA) & Two More: Should You Follow Cryder Capital Into Its Top Picks? at Insider Monkey
Nov-13-16 04:45PM  Thermo Fisher shares could rise 30 pct over the next 2 years -Barron's
Nov-12-16 12:01AM  [$$] Thermo Fisher Has 30% Upside at Barrons.com
Nov-11-16 06:04PM  What Were Becton Dickinsons 4Q16 Growth Drivers?
Nov-10-16 04:30PM  Thermo Fisher Scientific Declares Quarterly Dividend Business Wire
01:04PM  THERMO FISHER SCIENTIFIC INC. Financials
09:30AM  The Zacks Analyst Blog Highlights: Thermo Fisher Scientific, Arch Capital Group, IPG Photonics, AngioDynamics and Express Scripts Holding
Nov-09-16 09:00AM  5 GARP Stocks to Buy Now
07:28AM  Thermo Fisher Scientific, Inc. breached its 50 day moving average in a Bullish Manner : TMO-US : November 9, 2016
Nov-08-16 08:30AM  Thermo Fisher Scientific and Hamilton Storage Partner to Simplify Sample Storage Business Wire
Nov-05-16 12:13PM  The Unsung Heroes of CAR-T at Motley Fool
Nov-04-16 12:12PM  THERMO FISHER SCIENTIFIC INC. Files SEC form 10-Q, Quarterly Report
10:00AM  How to Position Before the Presidential Election
08:15AM  Blog Coverage VWR Corporation Announces Two Acquisitions Accesswire
Nov-02-16 08:06AM  Thermo Fisher Scientific Updated Its 2016 Guidance
Nov-01-16 11:06AM  Analyzing Thermo Fisher Scientifics Recent Stock Performance
10:07AM  Highlights from Thermo Fisher Scientifics 3Q16 Earnings
08:46AM  5 Top Stocks with Imposing Earnings Growth
08:07AM  Analysts Recommendations for Thermo Fisher Scientific
Oct-31-16 02:13PM  ETFs with exposure to Thermo Fisher Scientific, Inc. : October 31, 2016
Oct-28-16 09:29AM  Thermo Fisher Scientific, Inc. :TMO-US: Earnings Analysis: Q3, 2016 By the Numbers : October 28, 2016
09:21AM  7 Dividend Stocks That Promise Stability and Growth
08:30AM  Thermo Fisher Scientific to Present at Bairds 2016 Industrial Conference on November 8, 2016 Business Wire
Oct-27-16 04:51PM  Edited Transcript of TMO earnings conference call or presentation 27-Oct-16 12:30pm GMT
11:30AM  [$$] Thermo Fisher Scientific Lifts Outlook at The Wall Street Journal
09:33AM  Thermo Fisher (TMO) Tops Q3 Earnings, Raises '16 Outlook
08:10AM  Thermo Fisher Scientific (TMO): Tops Q3 Earnings and Revenue
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables used in biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases. This segment serves pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. The company's Analytical Instruments segment provides instruments, consumables, software, and services for applications in the laboratory, on the production line, and in the field. This segment serves pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, calibrators, controls, and calibration verification fluids; blood-test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; and human leukocyte antigen typing and testing for the organ transplant market. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The company's Laboratory Products and Services segment offers sample preparation, storage, and preservation equipment; controlled temperature technology products; centrifugation products and biological safety cabinets; water analysis instruments and laboratory equipment; laboratory consumables; chemicals; research and safety market channel services; and biopharma services. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CASPER MARC NChief Executive OfficerSep 02Option Exercise54.9728,7971,582,971307,444Sep 06 04:52 PM
CASPER MARC NChief Executive OfficerSep 02Sale151.0128,7974,348,635278,647Sep 06 04:52 PM
CASPER MARC NChief Executive OfficerSep 01Option Exercise54.9730,0001,649,100308,647Sep 02 05:32 PM
CASPER MARC NChief Executive OfficerSep 01Sale151.1730,0004,535,076278,647Sep 02 05:32 PM
Shine Daniel PSenior Vice PresidentAug 29Sale152.281,699258,72417,437Aug 31 05:00 PM
Loewald Thomas WSenior Vice PresidentAug 29Sale152.283,256495,82435,814Aug 31 04:58 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Aug 29Sale152.282,270345,67627,384Aug 31 04:56 PM
Shine Daniel PSenior Vice PresidentAug 26Sale151.7847672,24719,136Aug 30 05:20 PM
Loewald Thomas WSenior Vice PresidentAug 26Sale151.92913138,70339,070Aug 30 05:17 PM
CASPER MARC NChief Executive OfficerAug 15Sale155.9625,0003,899,031295,998Aug 17 04:54 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Aug 10Sale156.005,023783,58831,914Aug 11 04:46 PM
HARRIS C MARTINDirectorAug 05Sale157.3339061,3594,648Aug 08 04:53 PM
Loewald Thomas WSenior Vice PresidentJul 13Option Exercise73.248,025587,75152,194Jul 14 04:35 PM
Loewald Thomas WSenior Vice PresidentJul 13Sale155.008,0251,243,87544,169Jul 14 04:35 PM
CASPER MARC NChief Executive OfficerJul 05Option Exercise54.9720,0001,099,400340,998Jul 07 04:42 PM
CASPER MARC NChief Executive OfficerJul 05Sale147.6920,0002,953,804320,998Jul 07 04:42 PM
CASPER MARC NChief Executive OfficerJul 01Option Exercise54.9730,0001,649,100350,998Jul 06 04:42 PM
CASPER MARC NChief Executive OfficerJul 01Sale148.8530,0004,465,638320,998Jul 06 04:42 PM
Shine Daniel PSenior Vice PresidentJun 15Option Exercise54.976,900379,29328,779Jun 16 05:00 PM
Shine Daniel PSenior Vice PresidentJun 15Sale148.316,9001,023,35621,879Jun 16 05:00 PM
WILVER PETER MExec. VP & Chief Admin OfficerJun 10Option Exercise54.9768,2003,748,954138,777Jun 14 04:47 PM
WILVER PETER MExec. VP & Chief Admin OfficerJun 10Sale152.3868,20010,392,63370,577Jun 14 04:47 PM
MANZI JIM PDirectorJun 03Sale153.001,137173,96138,733Jun 06 04:41 PM
Loewald Thomas WSenior Vice PresidentJun 02Option Exercise73.2415,0001,098,60059,169Jun 06 04:39 PM
Loewald Thomas WSenior Vice PresidentJun 02Sale152.8415,0002,292,60044,169Jun 06 04:39 PM
Williamson StephenSr. VP and CFOMay 25Option Exercise54.973,740205,58833,821May 26 04:38 PM
Williamson StephenSr. VP and CFOMay 24Option Exercise54.978,660476,04038,741May 26 04:38 PM
Williamson StephenSr. VP and CFOMay 24Sale150.298,6601,301,48330,081May 26 04:38 PM
HORNSTRA PETER EVP & Chief Accounting OfficerMay 16Option Exercise68.386,357434,69425,671May 17 11:39 AM
HORNSTRA PETER EVP & Chief Accounting OfficerMay 16Sale150.007,8111,171,65017,860May 17 11:39 AM
Shine Daniel PSenior Vice PresidentApr 26Option Exercise54.975,000274,85027,892Apr 27 04:09 PM
Shine Daniel PSenior Vice PresidentApr 26Sale146.006,013877,89821,879Apr 27 04:09 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Apr 05Option Exercise73.2410,000732,40046,937Apr 07 04:28 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Apr 05Sale141.8610,0001,418,58036,937Apr 07 04:28 PM
Durbin Patrick MSenior Vice PresidentApr 04Option Exercise64.3911,250724,37944,348Apr 06 04:21 PM
Durbin Patrick MSenior Vice PresidentApr 04Sale142.1816,2502,310,42528,098Apr 06 04:21 PM
Williamson StephenSr. VP and CFOMar 22Option Exercise51.634,592237,07830,081Mar 23 04:36 PM
Williamson StephenSr. VP and CFOMar 21Option Exercise51.7510,708554,09536,197Mar 23 04:36 PM
Williamson StephenSr. VP and CFOMar 21Sale139.5010,7081,493,76625,489Mar 23 04:36 PM
CASPER MARC NChief Executive OfficerMar 14Sale139.2830,0004,178,296320,998Mar 16 05:40 PM
Malus Alan JExecutive Vice PresidentMar 10Option Exercise126.3925,9253,276,78873,211Mar 14 04:47 PM
Malus Alan JExecutive Vice PresidentMar 10Sale139.0525,9253,604,80947,286Mar 14 04:47 PM
Malus Alan JExecutive Vice PresidentMar 09Option Exercise73.2411,525844,09162,732Mar 11 04:07 PM
Malus Alan JExecutive Vice PresidentMar 09Sale138.5015,4462,139,29047,286Mar 11 04:07 PM
SPERLING SCOTT MDirectorMar 03Option Exercise36.8720,000737,40085,790Mar 07 04:31 PM
Loewald Thomas WSenior Vice PresidentMar 03Option Exercise49.493,625179,40147,794Mar 04 07:15 PM
Loewald Thomas WSenior Vice PresidentMar 03Sale137.283,625497,64044,169Mar 04 07:15 PM
SPERLING SCOTT MDirectorMar 03Sale137.905,350737,74580,440Mar 07 04:31 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Mar 01Sale135.002,951398,38536,937Mar 02 05:12 PM
Shine Daniel PSenior Vice PresidentFeb 29Sale130.2461479,96722,892Mar 02 04:50 PM
CRM salesforce.com, inc. daily Stock Chart
CRM [NYSE]
salesforce.com, inc.
IndexS&P 500 P/E277.35 EPS (ttm)0.29 Insider Own0.10% Shs Outstand699.17M Perf Week0.09%
Market Cap57.01B Forward P/E63.46 EPS next Y1.29 Insider Trans-75.04% Shs Float659.76M Perf Month4.61%
Income205.60M PEG9.80 EPS next Q0.25 Inst Own87.00% Short Float2.56% Perf Quarter10.26%
Sales7.91B P/S7.21 EPS this Y83.00% Inst Trans1.76% Short Ratio3.33 Perf Half Y1.72%
Book/sh9.86 P/B8.27 EPS next Y31.26% ROA1.50% Target Price94.16 Perf Year16.95%
Cash/sh1.72 P/C47.48 EPS next 5Y28.30% ROE3.50% 52W Range66.43 - 84.48 Perf YTD19.11%
Dividend- P/FCF37.33 EPS past 5Y-21.10% ROI0.00% 52W High-3.48% Beta1.31
Dividend %- Quick Ratio0.60 Sales past 5Y32.10% Gross Margin74.10% 52W Low22.75% ATR1.22
Employees19000 Current Ratio0.60 Sales Q/Q25.30% Oper. Margin1.30% RSI (14)68.12 Volatility1.22% 1.56%
OptionableYes Debt/Eq0.37 EPS Q/Q-42.60% Profit Margin2.60% Rel Volume0.65 Prev Close81.78
ShortableYes LT Debt/Eq0.37 EarningsFeb 28 AMC Payout0.00% Avg Volume5.08M Price81.54
Recom1.80 SMA201.22% SMA507.39% SMA2006.18% Volume3,284,280 Change-0.29%
Feb-16-17Initiated Needham Hold
Jan-12-17Downgrade Pivotal Research Group Buy → Hold $105 → $76
Jan-11-17Initiated Wells Fargo Outperform
Nov-18-16Reiterated Wedbush Outperform $96 → $98
Nov-18-16Reiterated Mizuho Buy $85 → $95
Nov-18-16Reiterated BMO Capital Markets Outperform $86 → $90
Oct-18-16Initiated Rosenblatt Buy $90
Sep-01-16Reiterated Wedbush Outperform $98 → $96
Sep-01-16Reiterated RBC Capital Mkts Outperform $91 → $85
Sep-01-16Reiterated Mizuho Buy $100 → $85
Sep-01-16Reiterated BMO Capital Markets Outperform $98 → $86
Jun-15-16Initiated BMO Capital Markets Outperform $98
May-19-16Reiterated Wunderlich Buy $93 → $101
May-19-16Reiterated Wedbush Outperform $95 → $98
May-19-16Reiterated Stifel Buy $85 → $93
May-19-16Reiterated MKM Partners Buy $86 → $96
May-19-16Reiterated Mizuho Buy $90 → $100
May-19-16Reiterated Canaccord Genuity Buy $88 → $95
May-19-16Reiterated Barclays Overweight $88 → $89
May-17-16Reiterated Jefferies Hold $60 → $74
Feb-27-17 04:31PM  Workday Swings To Profit, Revenue Outlook Bullish, But Stock Falls
04:22PM  Trump Speech, Salesforce, Domino's, Ambarella: Investing Action Plan
04:18PM  Salesforce on track for record earnings despite competition at MarketWatch
04:02PM  Salesforce.com Earnings Preview: Billings, M&A Outlook Eyed
12:08PM  ServiceNow CEO Shuffle Surprises, Stock Falls
10:36AM  Analysts Views on Salesforce Stock
10:26AM  A Look At Expectations And Sentiment For Salesforce Ahead Of Earnings
09:06AM  Salesforces Value Proposition in the Software Space
08:41AM  Technology Stocks' Earnings on Feb 28: CRM, PANW & More
08:15AM  Post Earnings Coverage as Twilio Showed 60% Total Revenue Growth for Q4 FY16 Accesswire
07:35AM  Why Salesforce Has Caught Activist Investors Interest
07:30AM  Salesforce Vice Chairman, President & COO to Participate in Upcoming Investor Event PR Newswire
Feb-26-17 10:59PM  Otherlevels Holdings Ltd (ASX:OLV) Half-Year Results Presentation ABN Newswire
08:27AM  Earnings Preview: What To Expect From Salesforce.com On Tuesday at Forbes
Feb-24-17 04:34PM  3 Cloud Stocks that Turned $7,000 into Over $100,000 at Motley Fool
04:28PM  Google Plays Catch-Up In The Cloud With Amazon And Microsoft
01:28PM  Can Salesforce Beat the Competition? Gurufocus
10:47AM  Why Apple Won't Be Hurt by Denouncing Trump's Transgender Policy Rollback
10:36AM  What Could Boost Salesforce in 2017 at Market Realist
09:54AM  Salesforce (CRM) to Report Q4 Earnings: What's in Store?
09:06AM  Will Salesforce Continue Its Buying Spree in 2017?
07:37AM  Salesforce and IBM Are Keen on Exploring the Digital Space
Feb-23-17 02:25PM  Earnings Preview: Salesforce Q4 2017 (CRM)
10:39AM  Why Salesforce Was Named a Digital Marketing Hub Leader at Market Realist
09:46AM  A Look at Why Salesforce Acquired Sequence
09:40AM  Heres What LinkedIn Did to Microsoft in 2Q17 at Market Realist
08:02AM  Why Salesforce Is Set to Grow in 2017 at Market Realist
Feb-22-17 06:05PM  How Salesforces US Dependence Could Help It
05:39PM  Trader makes the case for Salesforce.com
04:13PM  What Investors Can Expect from Salesforce in 4Q17 at Market Realist
12:08PM  Salesforce Expected To Deliver Across The Board Beat In Q4
Feb-21-17 04:15PM  Meet The 'Fastest-Growing' $1 Billion Enterprise Software Firm
10:18AM  SaaSy B2B Sales Are in the Clouds
Feb-20-17 06:05PM  Why Ciscos Collaboration Revenue Rose in Fiscal 2Q17
08:15AM  Salesforce Positioned in the Leaders Quadrant of the Magic Quadrant for Digital Marketing Hubs PR Newswire
08:00AM  Salesforce Supercharges Health Cloud with New Capabilities and Expanded Partner Ecosystem PR Newswire
Feb-19-17 10:11PM  How the Leaders of Enterprise Management SaaS are Growing Gurufocus
Feb-17-17 05:26PM  Final Trade: NKE, BA & more
12:21PM  10 Biggest Enterprise Software Companies In The World at Insider Monkey
12:08PM  salesforce.com or Workday? Piper Says: Just Buy Them Both at Motley Fool
Feb-16-17 10:35AM  Why Microsoft Is Keeping a Close Eye on Salesforces Moves at Market Realist
09:44AM  Cisco (CSCO) Q2 Earnings Beat, Revenues Miss; View Dim
07:35AM  Coverage initiated on Salesforce.com by Needham
Feb-15-17 05:48PM  Salesforce's hiring of ex-Oracle exec Keith Block is paying off in a big way Business Insider
03:55PM  Potential Activist Funds Line Up to Take a Salesforce Stake at Bloomberg
02:15PM  Seven Million Reasons Why Jack Dorsey Isn't Likely to Leave Twitter Anytime Soon
10:36AM  Why Oracle Isnt Sitting Easy
09:30AM  The Zacks Analyst Blog Highlights: Wix.com, Salesforce.com and Attunity
Feb-14-17 03:34PM  E-Commerce Merchants Can Get Card Transactions Guaranteed at Forbes
03:24PM  3 Cloud Stocks To Buy Right Now
Feb-13-17 11:46AM  Steven Mnuchin to be confirmed to Treasury, but role still undefined
08:35AM  Are Options Traders Betting on a Big Move in Salesforce.com (CRM) Stock?
08:00AM  Salesforce Introduces Service Cloud Einstein, the World's #1 Intelligent Customer Service Platform PR Newswire
Feb-12-17 08:07AM  African-Americans are more likely to get hired, but get paid less in tech industry
Feb-10-17 04:22PM  Twitter Is Ignoring the Most Obvious Problem Gurufocus
09:00AM  Twitter Isn't the Emperor, but It Definitely Has No Clothes
Feb-09-17 06:09PM  How salesforce.com, Inc. Gained 15.5% in January at Motley Fool
Feb-08-17 06:00AM  Trumponomics Could Push 2017 Software M&A's Higher at Investopedia
05:13AM  Decoding Salesforce's Strategy For Productized Analytics at Forbes
Feb-07-17 04:05PM  Salesforce Delivers Next-Generation Productivity for Customers with New Innovations in Quip PR Newswire
04:05PM  Salesforce Announces Timing of its Fiscal 2017 Fourth Quarter and Full Year Financial Results Conference Call PR Newswire
03:00PM  Twitter Makes Its Latest Push to Combat Harassment
11:25AM  [$$] Twitter steps up efforts to combat abuse as user growth slows at Financial Times
Feb-06-17 05:59PM  Final Trade: CRM, V & more
03:53PM  A list of the 97 companies opposing Trump's travel ban
01:07AM  [$$] US tech groups file action against Trump migrant ban at Financial Times
Feb-05-17 12:05PM  Why Salesforce.com Stock Fell 12% in 2016 at Motley Fool
Feb-03-17 04:35PM  Microsoft Could Rattle These Rivals with Maluuba
Feb-02-17 04:54PM  Could Google Bid For Salesforce.com Despite Amazon Cloud Pact?
02:56PM  Valley National Bank CIO Preps Move From 'All Paper' to CRM at The Wall Street Journal
12:00PM  ServiceNow Invests In MapAnything In Platform Ecosystem Play at Forbes
Feb-01-17 04:04PM  Could Salesforce.com Buy Microsoft Rival Slack Technologies?
08:00AM  Salesforce Provides U.S. Department of Agriculture with Technology to Connect American Farmers and Ranchers with More Resources PR Newswire
Jan-30-17 04:01PM  Will Microsoft Stymie Salesforce.com's Stock Turnaround?
12:45PM  Unusual activity: Bulls target Salesforce
Jan-29-17 05:00PM  Salesforce Execs Take Advantage of Market Rally at Investopedia
03:28AM  IBM's Most Competitive Business Unit Keeps Amazon, Microsoft Out
Jan-27-17 03:18PM  Weekly CFO Sells Highlights Gurufocus
Jan-26-17 03:59PM  Is Silicon Valley The New Frontier In Journalism?
Jan-25-17 04:42PM  Green: Schlumberger is a play for the future
09:05AM  Inside the Analyst Recommendations for Salesforce stock at Market Realist
07:35AM  Gauging Salesforces Value Proposition in the Software Space
Jan-24-17 10:36AM  Behind Salesforces Increase in Software Spending in 2017
09:05AM  What New EVP Monica Langley Could Mean for Salesforce
07:35AM  Why Is Salesforce Stock a Buy for UBS?
Jan-23-17 07:22PM  Cramer Remix: Stocks that benefit in a Trump-free zone at CNBC
04:36PM  Salesforce Open to More Acquisitions (CRM) at Investopedia
10:36AM  Understanding Salesforces Partnership with AmazonAnd Why It Matters at Market Realist
09:12AM  Salesforce Versus Gender Pay Gap Round 2 at Investopedia
09:06AM  Salesforces M&As in 2017: A Slowdown Ahead?
08:31AM  Salesforce.com Looks Like a Buy on Strength
08:01AM  Salesforce Grants Equity Awards Under Its Inducement Equity Incentive Plan PR Newswire
07:36AM  Did Salesforce Stock Bear the Brunt of Its Buyout Spree in 2016?
Jan-22-17 01:05PM  Davos Highlights AI's Massive PR Problem at Forbes
Jan-20-17 10:36AM  Why Salesforce Acquired Twin Prime
09:07AM  Inside Salesforces Focus in 2017 at Market Realist
07:38AM  Why Salesforce Is Likely to Grow in 2017
Jan-19-17 11:30PM  [$$] Tech leaders at Davos fret over effect of AI on jobs at Financial Times
06:58PM  Quip Acquires Unity and Variety
05:35PM  Why Salesforce Has to Be Ambitious in Revenue Growth at Market Realist
salesforce.com, inc. provides enterprise cloud computing solutions, with a focus on customer relationship management to various businesses and industries worldwide. It offers enterprise cloud computing applications and platform services, including Sales Cloud that enables companies to store data, monitor leads and progress, forecast opportunities, gain insights through relationship intelligence, and collaborate around sales on desktop and mobile devices. The company also provides Service Cloud that enables companies to deliver personalized customer service and support, as well as connects their service agents with customers on various devices; and Marketing Cloud, which enables companies to plan, personalize, and optimize customer interactions. In addition, it offers Community Cloud that enables companies to engage with groups of people by giving them access to information, applications, and experts; Analytics Cloud, an application, which enables companies to deploy sales, service, marketing, and custom analytics applications using various data source; Internet of Things Cloud that enables customers to process data, as well as build personalized actions and engage with customers in real time; and App Cloud, an application development platform for companies to deliver connected applications for various business needs. Further, the company provides professional services, including consulting, deployment, training, and design and integration services to facilitate the adoption of its cloud solutions, as well as offers various education service offerings ranging from introductory online courses to advanced architecture certifications. It sells and markets services primarily through its direct sales force, as well as through consulting firms, systems integrators, and regional partners. The company has a strategic alliance with Cisco to develop IoT and contact center platforms. salesforce.com, inc. was founded in 1999 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Benioff MarcChairman of the Board and CEOFeb 24Option Exercise39.0910,000390,92534,195,300Feb 24 08:39 PM
Allanson JoeChief Accounting OfficerFeb 24Sale81.4117113,92129,353Feb 24 08:33 PM
Benioff MarcChairman of the Board and CEOFeb 24Sale81.4510,000814,53034,185,300Feb 24 08:39 PM
BLOCK KEITHPres., Vice Chairman and COOFeb 23Option Exercise37.9510,000379,50010,000Feb 23 06:45 PM
Benioff MarcChairman of the Board and CEOFeb 23Option Exercise39.0910,000390,92534,195,300Feb 23 08:05 PM
BLOCK KEITHPres., Vice Chairman and COOFeb 23Sale82.5610,000825,5560Feb 23 06:45 PM
Benioff MarcChairman of the Board and CEOFeb 23Sale82.2510,000822,49234,185,300Feb 23 08:05 PM
Allanson JoeChief Accounting OfficerFeb 23Sale82.3013711,27629,524Feb 23 08:07 PM
Dayon AlexandrePres. & Chief Product OfficerFeb 23Sale82.3047138,76522,314Feb 23 08:53 PM
Harris ParkerCo-FounderFeb 23Sale82.3035629,30038,619Feb 23 09:27 PM
Hawkins Mark JChief Financial OfficerFeb 23Sale82.3035329,05311,479Feb 23 09:29 PM
Martinez MariaPres., Sales & Cust. SuccessFeb 23Sale82.3020616,95533,471Feb 23 09:31 PM
Norton Burke FEVP and Chief Legal OfficerFeb 23Sale82.3037330,69977,975Feb 23 09:32 PM
Weaver Amy EEVP, General CounselFeb 23Sale82.30584,77416,510Feb 23 09:38 PM
Roos John VictorDirectorFeb 23Sale82.2414411,84318,922Feb 23 06:41 PM
Benioff MarcChairman of the Board and CEOFeb 22Option Exercise39.0910,000390,92534,195,300Feb 22 08:51 PM
Allanson JoeChief Accounting OfficerFeb 22Option Exercise0.00308029,661Feb 23 08:07 PM
Dayon AlexandrePres. & Chief Product OfficerFeb 22Option Exercise0.001,234022,785Feb 23 08:53 PM
Harris ParkerCo-FounderFeb 22Option Exercise0.00926038,975Feb 23 09:27 PM
Hawkins Mark JChief Financial OfficerFeb 22Option Exercise0.00926011,832Feb 23 09:29 PM
Martinez MariaPres., Sales & Cust. SuccessFeb 22Option Exercise0.00463033,677Feb 23 09:31 PM
Norton Burke FEVP and Chief Legal OfficerFeb 22Option Exercise0.00926078,348Feb 23 09:32 PM
Weaver Amy EEVP, General CounselFeb 22Option Exercise0.00154016,568Feb 23 09:38 PM
Benioff MarcChairman of the Board and CEOFeb 22Sale82.0710,000820,66534,185,300Feb 22 08:51 PM
Benioff MarcChairman of the Board and CEOFeb 21Option Exercise39.0910,000390,92534,195,300Feb 21 08:26 PM
BLOCK KEITHPres., Vice Chairman and COOFeb 21Option Exercise37.9510,000379,50010,000Feb 21 08:31 PM
Benioff MarcChairman of the Board and CEOFeb 21Sale82.0010,000820,02434,185,300Feb 21 08:26 PM
BLOCK KEITHPres., Vice Chairman and COOFeb 21Sale81.8510,000818,5130Feb 21 08:31 PM
Benioff MarcChairman of the Board and CEOFeb 17Option Exercise39.0910,000390,92534,195,300Feb 17 06:55 PM
Benioff MarcChairman of the Board and CEOFeb 17Sale81.1010,000811,02134,185,300Feb 17 06:55 PM
Benioff MarcChairman of the Board and CEOFeb 16Option Exercise39.0910,000390,92534,195,300Feb 16 09:29 PM
BLOCK KEITHPres., Vice Chairman and COOFeb 16Option Exercise37.9510,000379,50010,000Feb 16 09:32 PM
Roos John VictorDirectorFeb 16Sale81.6814411,76217,348Feb 16 07:44 PM
Benioff MarcChairman of the Board and CEOFeb 16Sale80.9810,000809,83834,185,300Feb 16 09:29 PM
BLOCK KEITHPres., Vice Chairman and COOFeb 16Sale81.3910,000813,9210Feb 16 09:32 PM
Benioff MarcChairman of the Board and CEOFeb 15Option Exercise39.0910,000390,92534,195,300Feb 16 09:29 PM
Conway CraigDirectorFeb 15Sale81.2025020,3008,993Feb 15 08:39 PM
Benioff MarcChairman of the Board and CEOFeb 15Sale81.6310,000816,33334,185,300Feb 16 09:29 PM
Benioff MarcChairman of the Board and CEOFeb 14Option Exercise39.0910,000390,92534,195,300Feb 14 06:57 PM
BLOCK KEITHPres., Vice Chairman and COOFeb 14Option Exercise37.9510,000379,50010,000Feb 14 07:08 PM
Benioff MarcChairman of the Board and CEOFeb 14Sale80.9310,000809,30534,185,300Feb 14 06:57 PM
BLOCK KEITHPres., Vice Chairman and COOFeb 14Sale80.8710,000808,6940Feb 14 07:08 PM
Benioff MarcChairman of the Board and CEOFeb 13Option Exercise39.0910,000390,92534,195,300Feb 13 08:42 PM
Benioff MarcChairman of the Board and CEOFeb 13Sale80.9110,000809,12434,185,300Feb 13 08:42 PM
Benioff MarcChairman of the Board and CEOFeb 10Option Exercise39.0910,000390,92534,195,300Feb 13 08:42 PM
Benioff MarcChairman of the Board and CEOFeb 10Sale80.8510,000808,48134,185,300Feb 13 08:42 PM
BLOCK KEITHPres., Vice Chairman and COOFeb 09Option Exercise37.9510,000379,50010,000Feb 09 08:58 PM
Benioff MarcChairman of the Board and CEOFeb 09Option Exercise39.0910,000390,92534,195,300Feb 09 08:08 PM
BLOCK KEITHPres., Vice Chairman and COOFeb 09Sale81.1110,000811,0790Feb 09 08:58 PM
Roos John VictorDirectorFeb 09Sale80.7514411,62817,492Feb 09 08:05 PM
Benioff MarcChairman of the Board and CEOFeb 09Sale81.3310,000813,33234,185,300Feb 09 08:08 PM
Benioff MarcChairman of the Board and CEOFeb 08Option Exercise39.0910,000390,92534,195,300Feb 08 08:26 PM
Benioff MarcChairman of the Board and CEOFeb 08Sale80.5310,000805,30034,185,300Feb 08 08:26 PM
BLOCK KEITHPres., Vice Chairman and COOFeb 07Option Exercise37.9510,000379,50010,000Feb 07 08:39 PM
Benioff MarcChairman of the Board and CEOFeb 07Option Exercise39.0910,000390,92534,195,300Feb 07 08:20 PM
BLOCK KEITHPres., Vice Chairman and COOFeb 07Sale80.2510,000802,4600Feb 07 08:39 PM
Benioff MarcChairman of the Board and CEOFeb 07Sale80.0510,000800,45934,185,300Feb 07 08:20 PM
Benioff MarcChairman of the Board and CEOFeb 06Option Exercise39.0910,000390,92534,182,800Feb 06 09:25 PM
Wojcicki SusanDirectorFeb 06Buy79.611,25699,98722,612Feb 06 06:54 PM
Benioff MarcChairman of the Board and CEOFeb 06Sale79.6810,000796,80334,185,300Feb 06 09:25 PM
Benioff MarcChairman of the Board and CEOFeb 03Option Exercise39.0910,000390,92534,182,800Feb 06 09:25 PM
Benioff MarcChairman of the Board and CEOFeb 03Sale80.2810,000802,78134,172,800Feb 06 09:25 PM
BLOCK KEITHPres., Vice Chairman and COOFeb 02Option Exercise37.9510,000379,50010,000Feb 02 08:40 PM
Benioff MarcChairman of the Board and CEOFeb 02Option Exercise39.0910,000390,92534,155,500Feb 02 08:43 PM
Roos John VictorDirectorFeb 02Sale78.1914411,25917,636Feb 02 08:30 PM
BLOCK KEITHPres., Vice Chairman and COOFeb 02Sale78.6710,000786,6540Feb 02 08:40 PM
Benioff MarcChairman of the Board and CEOFeb 02Sale79.5410,000795,35034,145,500Feb 02 08:43 PM
Benioff MarcChairman of the Board and CEOFeb 01Option Exercise39.0910,000390,92534,155,500Feb 02 08:43 PM
Benioff MarcChairman of the Board and CEOFeb 01Sale78.3310,000783,32334,145,500Feb 02 08:43 PM
BLOCK KEITHPres., Vice Chairman and COOJan 31Option Exercise37.9510,000379,50010,000Jan 31 09:37 PM
Benioff MarcChairman of the Board and CEOJan 31Option Exercise39.0910,000390,92534,155,500Jan 31 09:06 PM
BLOCK KEITHPres., Vice Chairman and COOJan 31Sale79.0710,000790,6680Jan 31 09:37 PM
Benioff MarcChairman of the Board and CEOJan 31Sale78.7710,000787,69134,145,500Jan 31 09:06 PM
Benioff MarcChairman of the Board and CEOJan 30Option Exercise39.0910,000390,92534,155,500Jan 30 07:53 PM
Benioff MarcChairman of the Board and CEOJan 30Sale77.9710,000779,65234,145,500Jan 30 07:53 PM
Benioff MarcChairman of the Board and CEOJan 27Option Exercise39.0910,000390,92534,155,500Jan 27 06:33 PM
Benioff MarcChairman of the Board and CEOJan 27Sale78.1610,000781,58134,145,500Jan 27 06:33 PM
Benioff MarcChairman of the Board and CEOJan 26Option Exercise39.0910,000390,92534,155,500Jan 26 07:56 PM
BLOCK KEITHPres., Vice Chairman and COOJan 26Option Exercise37.9510,000379,50010,000Jan 26 08:24 PM
Hawkins Mark JChief Financial OfficerJan 26Option Exercise59.648,624514,33519,530Jan 26 08:35 PM
Benioff MarcChairman of the Board and CEOJan 26Sale77.9310,000779,29834,145,500Jan 26 07:56 PM
BLOCK KEITHPres., Vice Chairman and COOJan 26Sale78.5710,000785,6600Jan 26 08:24 PM
Hawkins Mark JChief Financial OfficerJan 26Sale78.518,624677,07110,906Jan 26 08:35 PM
Roos John VictorDirectorJan 26Sale79.0014411,37617,780Jan 26 08:38 PM
Benioff MarcChairman of the Board and CEOJan 25Option Exercise39.0910,000390,92534,155,500Jan 25 08:38 PM
BLOCK KEITHPres., Vice Chairman and COOJan 25Option Exercise37.95150,0005,692,500150,000Jan 25 08:51 PM
Benioff MarcChairman of the Board and CEOJan 25Sale78.1910,000781,85434,145,500Jan 25 08:38 PM
BLOCK KEITHPres., Vice Chairman and COOJan 25Sale78.00150,00011,700,0000Jan 25 08:51 PM
Benioff MarcChairman of the Board and CEOJan 24Option Exercise39.0910,000390,92534,155,500Jan 24 07:08 PM
Benioff MarcChairman of the Board and CEOJan 24Sale76.6510,000766,54934,145,500Jan 24 07:08 PM
Benioff MarcChairman of the Board and CEOJan 23Option Exercise39.0910,000390,92534,155,500Jan 24 07:08 PM
Benioff MarcChairman of the Board and CEOJan 23Sale76.1710,000761,71034,145,500Jan 24 07:08 PM
Weaver Amy EEVP, General CounselJan 23Sale76.2357143,52816,414Jan 23 08:35 PM
Robbins Cynthia G.EVP, Global Employee SuccessJan 23Sale76.2357143,528946Jan 23 08:47 PM
Weaver Amy EEVP, General CounselJan 22Option Exercise0.001,287016,985Jan 23 08:35 PM
Robbins Cynthia G.EVP, Global Employee SuccessJan 22Option Exercise0.001,28701,517Jan 23 08:47 PM
Benioff MarcChairman of the Board and CEOJan 20Option Exercise39.0910,000390,92534,155,500Jan 20 07:21 PM
Benioff MarcChairman of the Board and CEOJan 20Sale75.8510,000758,52334,145,500Jan 20 07:21 PM
Benioff MarcChairman of the Board and CEOJan 19Option Exercise39.0910,000390,92534,155,500Jan 19 07:23 PM
Benioff MarcChairman of the Board and CEOJan 19Sale75.6010,000756,02034,145,500Jan 19 07:23 PM
AGN Allergan plc daily Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-3.12 Insider Own0.20% Shs Outstand377.62M Perf Week-0.16%
Market Cap92.99B Forward P/E13.85 EPS next Y17.78 Insider Trans0.82% Shs Float374.18M Perf Month17.15%
Income-1219.50M PEG- EPS next Q3.38 Inst Own82.90% Short Float4.27% Perf Quarter27.89%
Sales14.57B P/S6.38 EPS this Y63.30% Inst Trans-7.47% Short Ratio3.96 Perf Half Y4.50%
Book/sh221.28 P/B1.11 EPS next Y10.83% ROA- Target Price268.74 Perf Year-17.15%
Cash/sh35.02 P/C7.03 EPS next 5Y13.63% ROE- 52W Range183.98 - 300.47 Perf YTD17.59%
Dividend2.80 P/FCF- EPS past 5Y-28.70% ROI- 52W High-18.04% Beta1.15
Dividend %1.14% Quick Ratio- Sales past 5Y26.00% Gross Margin87.20% 52W Low33.85% ATR4.87
Employees31200 Current Ratio- Sales Q/Q7.10% Oper. Margin-12.50% RSI (14)74.91 Volatility1.36% 2.44%
OptionableYes Debt/Eq- EPS Q/Q85.70% Profit Margin- Rel Volume0.58 Prev Close245.37
ShortableYes LT Debt/Eq- EarningsFeb 08 BMO Payout0.00% Avg Volume4.03M Price246.25
Recom2.00 SMA203.77% SMA5012.28% SMA2008.45% Volume2,353,475 Change0.36%
Feb-09-17Reiterated Mizuho Buy $273 → $275
Dec-09-16Reiterated Credit Suisse Outperform $301 → $274
Nov-17-16Reiterated Mizuho Buy $293 → $273
Nov-03-16Reiterated RBC Capital Mkts Outperform $300 → $279
Nov-01-16Reiterated Mizuho Buy $299 → $293
Oct-31-16Resumed Barclays Equal Weight $250
Oct-11-16Reiterated Mizuho Buy $305 → $299
Aug-19-16Upgrade Mizuho Neutral → Buy $248 → $318
Aug-09-16Reiterated RBC Capital Mkts Outperform $307 → $300
Aug-09-16Reiterated Deutsche Bank Buy $282 → $278
Aug-05-16Reiterated Mizuho Neutral $232 → $246
Jul-27-16Reiterated Leerink Partners Outperform $272 → $294
Jul-25-16Initiated Credit Suisse Outperform $327
May-13-16Reiterated Mizuho Neutral $250 → $232
Apr-18-16Resumed Goldman Buy $275
Apr-18-16Initiated Guggenheim Neutral
Apr-18-16Downgrade Piper Jaffray Overweight → Neutral $311 → $238
Apr-07-16Resumed Morgan Stanley Overweight $300
Apr-07-16Resumed JP Morgan Overweight
Apr-07-16Reiterated UBS Buy $366 → $300
Feb-27-17 05:12PM  Drugmakers pledge restraint, but prices will still soar
04:30PM  Allergan to Present at Raymond James 38th Annual Institutional Investors Conference PR Newswire
04:30PM  Allergan to Present at Cowen and Company 37th Annual Health Care Conference PR Newswire
03:55PM  The eyes have it in Allergan's new ad campaign from FCB Chicago at bizjournals.com
01:23PM  Jim Cramer Is Passing on Valeant Ahead of Earnings
12:48PM  Johnson & Johnson reveals 3.5% net hike in drug pricing l...
09:30AM  The Zacks Analyst Blog Highlights: IBM, Allergan, Chubb, DISH Network and HP
09:06AM  Eli Lilly & Co.s Oncology Franchise
08:00AM  Lisa DeFrancesco, Vice President of Investor Relations, to Leave Allergan PR Newswire
07:30AM  Allergan's New Eyepowerment Campaign Urges The Up To 33 Million Americans Suffering from Symptoms of Chronic Dry Eye to Take Action PR Newswire
06:00AM  Drugmakers Eye $35B Market Amid Obesity Crisis at Investopedia
01:51AM  Facing Criticism, Drug Makers Keep Lid On Price Increases at The Wall Street Journal
Feb-26-17 08:03PM  Drug Companies Keep Lid on Price Increases at The Wall Street Journal
12:28PM  Insider Q&A: Allergan CEO on impact of limiting price hikes
Feb-24-17 05:13PM  ALLERGAN PLC Files SEC form 10-K, Annual Report
01:21PM  NASH Is Todd Hagopian's Top Biotech Sub-Sector For 2017 at Forbes
10:58AM  Top Research Reports for February 24, 2017
Feb-23-17 05:15PM  Eli Lilly & Co.s Revenues in 4Q16
09:41AM  Pernix Therapeutics surges 42% after patent case win against generic from Actavis Labs at MarketWatch
Feb-22-17 09:14PM  Allergan CEO Pushes for Trump to Lead Drug Price Discussions
10:34AM  Ironwood (IRWD) Q4 Loss Narrower than Expected; Sales Top
08:01AM  Allergan to Sponsor Alzheimer's Foundation of America '15th Anniversary National Educating America' Tour PR Newswire
Feb-21-17 10:58AM  Medtronic Earnings Rebound in Third Quarter, Shares Climb
09:30AM  The Zacks Analyst Blog Highlights: Merck, Valeant Pharmaceuticals International, Allergan, AstraZeneca and Johnson & Johnson
12:01AM  [$$] Big pharma bets billions on 'silent' liver disease at Financial Times
Feb-17-17 09:00PM  Riddle Me This; Bendable Market: Best of Kass
05:15PM  Stull, Stull & Brody is Investigating Claims on Behalf of Allergans (NYSE:AGN) 401(k) Plan GlobeNewswire
04:22PM  Deals of the Week: Valentine Couplings and Breakups
07:21AM  Pharma Stock Roundup: Merck's Alzheimer's Study Halted, Allergan to Buy ZELTIQ
Feb-16-17 06:55PM  Why This Billionaire Just Shelled Out $1.1 Billion on 4 Drug Stocks at Motley Fool
05:38PM  Stress boom to boost drug sales?
12:06PM  David Tepper Invests Heavily in Pharma in 4th Quarter
Feb-15-17 03:03PM  5 Ways Allergan Can Keep Up Momentum
02:54PM  Tepper's Appaloosa Fund Continues Bet on Drug Companies in Q4 2016 at Investopedia
02:18PM  Tepper's Appaloosa triples stake in Allergan
01:24PM  Billionaire Dan Loebs Biggest Q4 Moves Include Bank-Buying Spree, Selling Allergan (AGN) at Insider Monkey
07:00AM  Medicines360 And Allergan Announce Partnership With Health Centers To Help Address Unintended Pregnancies In Areas Impacted By Zika PR Newswire
Feb-14-17 05:52PM  What the Smart Money's buying
05:32PM  David Tepper Increases Wagers on Drug Companies at The Wall Street Journal
05:22PM  Bets on financials, pharma power U.S. hedge funds' strong start to year Reuters
05:19PM  David Tepper's Appaloosa just dropped about $1 billion on 4 pharma stocks
04:54PM  Appaloosa Management snaps up Allergan shares in 4th quarter at MarketWatch
04:09PM  Hologic Follows Allergan, Buying Body-Sculptor Cynosure For $1.65 Bil
03:37PM  Sachem Head's Ferguson to exit Autodesk board, fund gains -letter
02:13PM  ETFs with exposure to Allergan Plc : February 14, 2017
09:45AM  Today's Research Reports on Stocks to Watch: Teva Pharmaceutical Industries and Allergan Accesswire
09:24AM  Valeant, Pershing Square to Split Legal Fees on Allergan Lawsuit
08:20AM  Teva (TEVA) Tops on Q4 Earnings, Maintains 2017 Guidance
08:15AM  Blog Coverage Allergan Acquires ZELTIQ; Set to Expand Presence in the Body Contouring Business Accesswire
07:07AM  Botox-maker Allergan is betting that zapping your fat is worth $4 billion at MarketWatch
06:26AM  New Relic: Cramer's Top Takeaways
Feb-13-17 11:48PM  Asian shares fall back as investors await comments by Yellen
05:57PM  Allergan Paying Nearly $2.5 Billion for ZELTIQ at Investopedia
05:30PM  Daniel Loeb Picks Up Rate-Sensitive Financials, Drops Pharma
05:18PM  Allergan Plc -- Moody's: Allergan's ZELTIQ acquisition credit negative on high pricetag at Moody's
05:11PM  Allergan To Acquire ZELTIQ in $2.47 Billion Deal, ZELTIQ Shares Pop 13%
04:51PM  Zeltiq, US Steel and Chemours rise; Hain Celestial plunges
04:40PM  Why Chemours, Zeltiq Aesthetics, and Vale Jumped Today at Motley Fool
04:34PM  Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 bln
04:05PM  Allergan To Buy Fat-Freezing Zeltiq For $2.5 Bil; Zeltiq Hits Record High
04:00PM  STOCKS HIT ALL-TIME HIGHS: Here's what you need to know
02:24PM  Allergan Acquires Zeltiq Aesthetics for $2.48 Billion at Investopedia
01:26PM  How to Trade Monday's Most Active Stocks: BofA, Vale, Zeltiq, Teva and More
01:15PM  Allergan Acquires ZELTIQ For $2.47 Billion at Investopedia
12:56PM  Why Zeltiq Aesthetics Stock Is Surging Higher Today at Motley Fool
12:12PM  Allergan Shares Surge After Announcing Acquisition of Zeltiq Aesthetics at TheStreet
11:21AM  [$$] Allergan agrees to buy fat-freezing company for $2.47bn at Financial Times
11:11AM  [video]Allergan Shares Rise on $2.5B Deal for Body-Sculptor Zeltiq
11:00AM  Stocks Trade Above Record Closes, Apple Nears All-Time High
10:53AM  UPDATE 2-Allergan to buy Zeltiq Aesthetics for about $2.48 bln
10:31AM  Teva seeks CEO with pharma background to lead recovery efforts Reuters
09:39AM  Morning Movers: Verizon Falls, Teva Jumps, Hain Celestial Craters at Barrons.com
09:34AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of ZELTIQ Aesthetics, Inc. to Allergan plc for $56.50 Per Share is Fair to Shareholders - ZLTQ Accesswire
09:32AM  [$$] Allergan to Buy Fat-Treatment Maker Zeltiq for $2.3 Billion at The Wall Street Journal
09:31AM  Verizon unlimited data is back, Burger King parent Restaurant Brands boosts profit, Allergan buys fat treatment company
08:51AM  Allergan to spend $2.48 B on CoolSculpting provider Zeltiq
08:15AM  Allergan to acquire body contouring company Zeltiq Aesthetics for $2.5 billion at MarketWatch
08:12AM  Allergan is buying a fat-freezing company for $2.5 billion
08:08AM  Allergan agrees to buy Zeltiq for about $2.48 bln
08:00AM  Allergan to Acquire ZELTIQ, Best-in-Class Company in Fast-Growing Body Contouring Segment, for $2.47 Billion PR Newswire
07:45AM  Early movers: AAPL, DD, TEVA, QSR, FDC, HAS, JCP & more at CNBC
05:00AM  [$$] SEC Letter to Allergan Hints at Additional non-GAAP Guidance at The Wall Street Journal
Feb-10-17 07:11PM  Cramer's Exec Cut: Why GE isnt worried about Trumps tra...
07:01PM  Cramer: Why Are People Dumping Such Good Stocks?
05:02PM  Dan Loeb took new stakes in J.P. Morgan, B. of A. and dumped Allergan at MarketWatch
04:10PM  Intercept Bounds To 3-Month High On NASH Trial Edits; Analysts Split
12:02PM  Allergan Plc :AGN-US: Earnings Analysis: 2016 By the Numbers : February 10, 2017
06:44AM  Pharma Stock Roundup: Allergan, GSK Top 4Q Earnings, Praluent Breather for Sanofi
Feb-09-17 04:15PM  Allergan to Present at The Leerink Partners 6th Annual Global Healthcare Conference PR Newswire
12:45PM  Cramer: Here's the Reason for Allergan's Remarkable Run
12:00PM  AASLD Foundation's Liver Disease Research and Education Initiatives Bolstered by Significant Donation from Allergan PR Newswire
10:10AM  Company News for February 09, 2017
09:40AM  Allergan Plc :AGN-US: Earnings Analysis: Q4, 2016 By the Numbers : February 9, 2017
09:30AM  Today's Research Reports on Gilead Sciences and Allergan Post Earnings Accesswire
08:43AM  How To Invest Like Seth Klarman
06:23AM  Allergan: Cramer's Top Takeaways
Feb-08-17 07:34PM  Cramer Remix: Why you would be an idiot to sell Disney at CNBC
07:18PM  Cramer Remix: The reason you would be an idiot to sell Di...
06:31PM  Is This Market in Trump-Bubble Territory? Cramer's 'Mad Money' Recap (Wednesday 2/8/17)
04:21PM  Allergan Leads Drug Stocks On View-Crushing Q4, 2016, 2017 Guidance
Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Brands, US Medical Aesthetics, International Brands, and Anda Distribution segments. The company offers a portfolio of products that provide treatments for the central nervous system, gastroenterology, women's health and urology, ophthalmology, neurosciences, medical aesthetics, liver disease, inflammation, fibrosis, and HIV, as well as dermatology and plastic surgery, and Alzheimer's disease. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. In addition, it distributes generic and branded pharmaceutical products primarily to independent pharmacies, pharmacy chains, pharmacy buying groups, and physicians' offices. Further, the company develops, processes, and markets tissue-based products for use in reconstructive, orthopedic, and urogynecologic surgical procedures to repair soft tissue defects. Allergan plc has a collaboration with T2 Biosystems to develop blood-based diagnostic panel for the detection of Gram-negative bacterial species. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Meury WilliamChief Commercial OfficerDec 08Option Exercise109.1211,8071,288,38048,866Feb 14 09:13 PM
Basgoz NesliDirectorDec 08Sale188.7250094,3605,515Dec 09 05:56 PM
SAUNDERS BRENT LCEO and PresidentNov 21Buy189.135,250992,941106,564Nov 21 04:03 PM
Hilado Maria TeresaChief Financial OfficerNov 11Buy210.641,422299,53613,379Nov 15 05:18 PM
ADBE Adobe Systems Incorporated daily Stock Chart
ADBE [NASD]
Adobe Systems Incorporated
IndexS&P 500 P/E51.20 EPS (ttm)2.32 Insider Own0.10% Shs Outstand495.71M Perf Week-0.74%
Market Cap58.88B Forward P/E24.74 EPS next Y4.80 Insider Trans-51.34% Shs Float492.30M Perf Month5.23%
Income1.17B PEG1.64 EPS next Q0.87 Inst Own88.80% Short Float1.07% Perf Quarter13.98%
Sales5.85B P/S10.06 EPS this Y86.70% Inst Trans-0.81% Short Ratio2.12 Perf Half Y16.81%
Book/sh14.98 P/B7.93 EPS next Y25.78% ROA9.50% Target Price123.96 Perf Year37.16%
Cash/sh9.61 P/C12.36 EPS next 5Y31.21% ROE16.10% 52W Range83.17 - 120.17 Perf YTD15.38%
Dividend- P/FCF29.50 EPS past 5Y7.00% ROI13.20% 52W High-1.16% Beta1.05
Dividend %- Quick Ratio2.10 Sales past 5Y6.80% Gross Margin86.00% 52W Low42.82% ATR1.49
Employees15706 Current Ratio2.10 Sales Q/Q23.10% Oper. Margin25.50% RSI (14)70.65 Volatility1.12% 1.20%
OptionableYes Debt/Eq0.00 EPS Q/Q81.40% Profit Margin20.00% Rel Volume0.62 Prev Close119.31
ShortableYes LT Debt/Eq0.26 EarningsMar 16 AMC Payout0.00% Avg Volume2.48M Price118.78
Recom2.00 SMA201.89% SMA507.05% SMA20014.38% Volume1,550,358 Change-0.44%
Feb-08-17Reiterated RBC Capital Mkts Outperform $115 → $125
Jan-12-17Downgrade Pivotal Research Group Buy → Hold $136 → $104
Jan-11-17Initiated Wells Fargo Market Perform
Jan-05-17Initiated BMO Capital Markets Outperform $125
Nov-03-16Reiterated Wunderlich Hold $99 → $115
Sep-21-16Reiterated RBC Capital Mkts Outperform $115 → $116
Sep-21-16Reiterated Pivotal Research Group Buy $124 → $125
Jul-26-16Initiated Piper Jaffray Overweight $125
Jun-22-16Reiterated UBS Buy $114 → $122
Jun-22-16Reiterated Rosenblatt Buy $112 → $120
Apr-21-16Resumed Credit Suisse Neutral $85 → $105
Apr-12-16Reiterated FBR Capital Mkt Perform $100 → $115
Apr-04-16Reiterated Dougherty & Company Buy $116 → $122
Mar-31-16Initiated Canaccord Genuity Buy $110
Mar-18-16Reiterated Wunderlich Hold $94 → $99
Mar-18-16Reiterated UBS Buy $105 → $114
Mar-18-16Reiterated RBC Capital Mkts Outperform $101 → $104
Mar-18-16Reiterated Dougherty & Company Buy $114 → $116
Jan-14-16Initiated Dougherty & Company Buy $114
Dec-14-15Reiterated Argus Buy $95 → $110
Feb-26-17 10:59PM  Otherlevels Holdings Ltd (ASX:OLV) Half-Year Results Presentation ABN Newswire
Feb-24-17 10:36AM  What Could Boost Salesforce in 2017 at Market Realist
Feb-23-17 10:39AM  Why Salesforce Was Named a Digital Marketing Hub Leader at Market Realist
12:01AM  Adobe Named a Leader in 2017 Gartner Magic Quadrant for Digital Marketing Hubs Business Wire
Feb-22-17 12:01AM  Adobe Unveils Worlds First Open, Cloud-Based Digital Signatures Business Wire
Feb-21-17 10:47AM  3 Aggressive Growth Stocks for 2017
Feb-18-17 08:28AM  20 companies that have met a high bar this earnings season at MarketWatch
01:25AM  [$$] Baird Sticks With Its Wal-Mart Rating and Target Price at Barrons.com
Feb-17-17 12:21PM  10 Biggest Enterprise Software Companies In The World at Insider Monkey
10:11AM  4 Stocks That Turned $1,000 into $100,000 at Motley Fool
Feb-16-17 09:49AM  Cisco's 'Better Than Feared' Q2 Results: What Wall Street's Saying at TheStreet
06:35AM  Adobe: Cramer's Top Takeaways
Feb-15-17 07:58PM  Stay Long, This Bull Is Strong: Cramer's 'Mad Money' Recap (Wednesday 2/15/17)
07:31PM  Cramer Remix: The market underestimates Facebook
07:25PM  Cramer Remix: The market understimates Facebook at CNBC
05:20PM  ADOBE SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers
09:21AM  3 Stocks at 52-Week Highs Still Worth Buying at Motley Fool
Feb-14-17 09:52AM  Adobe Systems Is Headed Still Higher at TheStreet
Feb-13-17 08:00AM  Media Alert: Adobe Data Shows Prices for Consumer Goods Increase Post Holiday Season Business Wire
Feb-10-17 07:01PM  Cramer: Why Are People Dumping Such Good Stocks?
11:48AM  How Google Chromebooks conquered schools AP
Feb-09-17 01:00PM  Investor Advisory: Adobe Announces Webcasts of Investor Conference Participation Business Wire
10:00AM  Here's Why Adobe Systems Incorporated Stock Will Continue To Soar at Motley Fool
09:34AM  These companies give new parents some amazing perks at MarketWatch
Feb-08-17 11:59AM  Autodesk Has Soared 95%, but Its Future Is Clouded by Pirates at TheStreet
Feb-07-17 12:29PM  The GAMCO Growth Fund 4th Quarter Commentary
Feb-06-17 02:00PM  Adobe's Path To Entering The Virtual Reality Story at Forbes
08:38AM  What Are We Expecting From Adobe? at Forbes
Feb-04-17 01:14PM  Top Tech Stocks to Buy in 2017 at Motley Fool
06:22AM  Autodesk: Cramer's Top Takeaways
06:21AM  Clorox: Cramer's Top Takeaways
Feb-03-17 04:18PM  Why Did Workday Stock Rise in January 2017?
04:09PM  Can Investors Build a Cheaper Amazon?
Feb-02-17 05:35AM  Adobe has become the latest US company to raise its prices in the UK following Brexit Business Insider
Feb-01-17 04:09PM  ADOBE SYSTEMS INC Files SEC form 8-K, Other Events
04:05PM  Adobes Board of Directors Elects Adobe CEO Shantanu Narayen as Chairman Business Wire
Jan-31-17 03:50PM  Adobe Systems Incorporated -- Moody's upgrades Adobe to A3 at Moody's
11:55AM  Adobe Announces Major Updates to Technical Communication Solutions Business Wire
Jan-30-17 04:01PM  Will Microsoft Stymie Salesforce.com's Stock Turnaround?
Jan-27-17 04:04PM  ADOBE SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Jan-26-17 06:11PM  Why a Toy Maker and a Coffee Company are Pushing Virtual Assistants at Motley Fool
01:04PM  ADOBE SYSTEMS INC Financials
01:25AM  Adobe Named a Leader in Web Content Management Systems Vendors by Independent Research Firm Business Wire
Jan-24-17 04:01PM  Nasdaq tops 5,600
11:48AM  Google Is Taking on Microsoft's Windows Cash Cow, and the Stakes Are High
10:00AM  Media Alert: Adobe Introduces New Applications for Select Chromebooks to Unlock Student Creativity Business Wire
Jan-23-17 04:23PM  Stocks Close Lower; Texas Instruments Breaks Out; 4 Key Companies To Post Earnings
10:32AM  No Trump Bump Yet As Stocks Slip; McDonald's Weighs On Dow; Nvidia Rises
10:07AM  Adobe Systems Is Ready for a Breakout and New Highs at TheStreet
08:32AM  Adobe Co-Founder Sells 5,000 Shares (ADBE) at Investopedia
08:31AM  25 Easy Ways To Stimulate Innovation, And Never Get Stuck Again at Forbes
08:03AM  Cohen Klingenstein Sells Adobe Shares (ADBE) at Investopedia
06:00AM  These 5 Big Stocks Look Ready for Blastoff in 2017
Jan-22-17 11:08AM  Amazon, Facebook, Adobe: 3 Tech Stocks Near Buys As Nasdaq At Highs
Jan-20-17 04:17PM  ADOBE SYSTEMS INC Files SEC form 10-K, Annual Report
09:07AM  Inside Salesforces Focus in 2017 at Market Realist
Jan-19-17 05:38PM  The US says Oracle is encouraging Indians to hire others Indiansand its killing diversity
05:35PM  Why Salesforce Has to Be Ambitious in Revenue Growth at Market Realist
04:42PM  Starbucks latest to expand parental leave benefits AP
02:44PM  APG Sells Adobe Systems Shares in 3Q16 (ADBE) at Investopedia
Jan-18-17 03:45PM  Adobe's Board OKs $2.5 Billion Share Buyback at Investopedia
10:10AM  Stock Market News for January 18, 2017
08:45AM  Adobe Gets Authorization to Repurchase Shares Worth $2.5B
08:28AM  Early movers: GS, TGT, UAL, CSX, NFLX, ADBE & more at CNBC
04:16AM  The CEO of ad tech firm TubeMogul explains why he sold his company to Adobe for $540 million and what happens now Business Insider
Jan-17-17 04:34PM  Pivotal Verifies Hold Rating for Adobe (ADBE) at Investopedia
04:19PM  ADOBE SYSTEMS INC Files SEC form 8-K, Other Events
04:19PM  Adobe System's board OKs $2.5B share buyback program at MarketWatch
04:05PM  Adobe Announces Program to Repurchase $2.5 Billion of Stock by End of FY2019 Business Wire
10:40AM  10 Biggest Cloud Computing Companies in the World at Insider Monkey
08:55AM  3 Top SaaS Companies to Buy Today at Motley Fool
08:52AM  Microsoft Acquires Maluuba, Expands in IoT and AI Markets
08:16AM  Can Adobe Lead in Digital Asset Management? (ADBE) at Investopedia
Jan-14-17 12:01AM  [$$] Credit Suisse Likes Expedia's Mash-Up of Brands at Barrons.com
Jan-13-17 12:56PM  Adobe Demos Voice-Controlled Photo Editing at Forbes
09:44AM  The Cure for the Annual Performance Review Is More Reviews
09:44AM  Performance Reviews Are Making Us Cry. We Might Not Like the Cure at Bloomberg
08:19AM  Why Splunk's Lower Guidance Should Make Investors Nervous at TheStreet
Jan-12-17 03:24PM  8 Stocks Jim Cramer Likes if the U.S. Economy Rebounds
02:50PM  Adobe Tries for Voice-Controlled Virtual Assistant at Investopedia
01:16PM  Morgan Stanley Adds Adobe Shares (MS, ADBE) at Investopedia
08:41AM  Adobe Systems downgraded by Pivotal Research Group
08:26AM  Zacks Upgrades Rating of Adobe Shares (ADBE) at Investopedia
Jan-11-17 02:45PM  Former Macy's Executive Rodriguez: Here's How To Regain Comp Store Sales
10:10AM  Stock Market News for January 11, 2017
09:56AM  Performance Review Peril: Adobe Study Shows Office Workers Waste Time and Tears Business Wire
07:58AM  Adobe Raises Revenue Guidance After TubeMogul Acquisition
Jan-10-17 04:10PM  How Will Adobe Systems Perform in 1QFY17? (ADBE) at Investopedia
02:33PM  Adobe Systems VP Sells 1,348 Shares (ADBE) at Investopedia
10:19AM  [$$] Adobe Co-Founder Sells $5 Million in Stock at Barrons.com
07:51AM  Buy Adobe Now -- Plus Jim Cramer's Take at TheStreet
Jan-09-17 04:40PM  Vetr Upgrades Adobe Shares to Buy (ADBE) at Investopedia
01:02PM  ShearLink Lowers Stake in Adobe Shares (ADBE) at Investopedia
12:49PM  Adobe Shares Rise 10.4 Percent in 2016 (ADBE) at Investopedia
11:23AM  Limited Stores Closes All 250 Stores as Another Retail Bankruptcy Looms
Jan-07-17 05:28PM  Why Adobe Systems Stock Rose 10.4% in 2016 at Motley Fool
10:10AM  Gigantic Tech and Financial Trades Dominate New Year Insider Selling: Google, Adobe Systems, Charles Schwab, Ingersoll-Rand and More
Jan-06-17 05:40PM  Adobe Should Shop for a Digital Commerce Platform: BMO Capital
03:10PM  Here are the 7 jobs that pay $100K or more on Glassdoor's 'Best Places to Work' list at bizjournals.com
11:09AM  Adobe Co-Chairman Sells 48,100 Shares (ADBE) at Investopedia
Adobe Systems Incorporated operates as a diversified software company worldwide. Its Digital Media segment provides tools and solutions that enable individuals, small and medium businesses, and enterprises to create, publish, promote, and monetize their digital content. This segment's flagship product is Creative Cloud, a subscription service that allows customers to download and install the latest versions of its creative products. This segment serves traditional content creators, Web application developers, and digital media professionals, as well as their management in marketing departments and agencies, companies, and publishers. The company's Digital Marketing segment offers solutions for how digital advertising and marketing are created, managed, executed, measured, and optimized. This segment provides analytics, social marketing, targeting, advertising and media optimization, digital experience management, cross-channel campaign management, and audience management solutions, as well as video delivery and monetization to digital marketers, advertisers, publishers, merchandisers, Web analysts, chief marketing officers, chief information officers, and chief revenue officers. Its Print and Publishing segment offers products and services, such as eLearning solutions, technical document publishing, Web application development, and high-end printing, as well as publishing needs of technical and business, and original equipment manufacturers (OEMs) printing businesses. The company markets and licenses its products and services directly to enterprise customers through its sales force, as well as to end-users through app stores and through its Website at adobe.com. It also distributes products and services through a network of distributors, value-added resellers, systems integrators, independent software vendors, retailers, and OEMs. The company was founded in 1982 and is headquartered in San Jose, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GARRETT MARKEVP, CFO & Asst. SecretaryFeb 06Sale114.1245,1995,158,0864,339Feb 07 04:10 PM
BURGESS ROBERT KDirectorFeb 02Option Exercise42.6125,0001,065,25062,124Feb 03 04:11 PM
BURGESS ROBERT KDirectorFeb 02Sale113.1925,0002,829,71037,124Feb 03 04:11 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryJan 27Sale113.0810,4401,180,54447,482Jan 27 04:14 PM
Rencher BradleyEVP & GM, Digital MarketingJan 25Sale113.9640,0004,558,27650,735Jan 26 04:14 PM
THOMPSON MATTHEWEVP WW Field OperationsJan 25Sale113.7855,0006,257,92851,919Jan 26 04:14 PM
NARAYEN SHANTANUPresident and CEOJan 25Sale113.91173,70319,787,246299,243Jan 26 04:13 PM
Rencher BradleyEVP & GM, Digital MarketingJan 24Option Exercise0.0080,7200101,620Jan 26 04:14 PM
ROWLEY RICHARDVP, Corp. Controller & CAOJan 24Option Exercise0.0013,748010,098Jan 26 04:14 PM
THOMPSON MATTHEWEVP WW Field OperationsJan 24Option Exercise0.00113,7560131,387Jan 26 04:14 PM
LAMKIN BRYANEVP & GM, Digital MediaJan 24Option Exercise0.0080,153078,016Jan 26 04:12 PM
Lewnes AnnEVP, Chief Marketing OfficerJan 24Option Exercise0.0056,620080,588Jan 26 04:12 PM
Morris DonnaEVP, Cust. & Emp. ExperienceJan 24Option Exercise0.0056,620089,524Jan 26 04:13 PM
NARAYEN SHANTANUPresident and CEOJan 24Option Exercise0.00363,2400549,812Jan 26 04:13 PM
Parasnis AbhayEVP & CTOJan 24Option Exercise0.008,16508,436Jan 26 04:13 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryJan 24Option Exercise0.0056,036068,744Jan 26 04:12 PM
GARRETT MARKEVP, CFO & Asst. SecretaryJan 24Option Exercise0.00103,587071,082Jan 26 04:12 PM
DALEY JAMES EDirectorJan 20Option Exercise33.2310,000332,30038,086Jan 23 04:58 PM
DALEY JAMES EDirectorJan 20Sale110.0210,0001,100,20028,086Jan 23 04:58 PM
WARNOCK JOHN ECo-Chairman of the BoardJan 17Sale107.285,000536,405559,600Jan 17 04:14 PM
GESCHKE CHARLES MCo-Chairman of the BoardJan 09Sale108.5223,1002,506,775228,773Jan 09 06:24 PM
ROWLEY RICHARDVP, Corp. Controller & CAOJan 06Sale108.131,348145,7600Jan 06 06:54 PM
GESCHKE CHARLES MCo-Chairman of the BoardJan 04Sale104.0348,1005,003,800251,873Jan 05 04:20 PM
WARNOCK JOHN ECo-Chairman of the BoardDec 19Sale105.416,000632,472565,600Dec 21 04:43 PM
Morris DonnaEVP, Cust. & Emp. ExperienceOct 10Sale110.0010,0001,100,00054,279Oct 11 04:43 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryOct 10Sale109.6413,3311,461,57930,993Oct 11 04:41 PM
WARNOCK JOHN ECo-Chairman of the BoardSep 27Sale106.995,000534,950571,600Sep 27 04:49 PM
ROSENSWEIG DANIELDirectorSep 26Sale107.4213,0001,396,4266,268Sep 27 04:47 PM
DALEY JAMES EDirectorSep 22Option Exercise33.236,276208,55134,362Sep 23 05:00 PM
DALEY JAMES EDirectorSep 22Sale108.006,276677,80828,086Sep 23 05:00 PM
GARRETT MARKEVP, CFO & Asst. SecretarySep 06Sale103.4726,8992,783,3120Sep 06 07:01 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryAug 29Sale101.855,450555,08344,324Aug 29 06:11 PM
Lewnes AnnEVP, Chief Marketing OfficerAug 26Sale101.6813113,32042,968Aug 29 04:29 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryAug 23Option Exercise0.0027,500064,123Aug 24 04:08 PM
GARRETT MARKEVP, CFO & Asst. SecretaryAug 16Option Exercise0.0056,250056,250Aug 17 04:31 PM
Morris DonnaEVP, Cust. & Emp. ExperienceAug 10Option Exercise34.032,33579,46076,614Aug 11 04:05 PM
Morris DonnaEVP, Cust. & Emp. ExperienceAug 10Sale100.0010,0001,000,00064,279Aug 11 05:06 PM
Morris DonnaEVP, Cust. & Emp. ExperienceAug 10Sale100.002,335233,50074,279Aug 11 04:05 PM
Lewnes AnnEVP, Chief Marketing OfficerJul 29Sale98.404,000393,60043,099Aug 01 04:09 PM
DALEY JAMES EDirectorJul 20Option Exercise33.235,000166,15033,086Jul 21 04:08 PM
WARNOCK JOHN ECo-Chairman of the BoardJul 20Sale98.512,000197,024579,115Jul 21 04:10 PM
DALEY JAMES EDirectorJul 20Sale98.505,000492,50028,086Jul 21 04:08 PM
BARNHOLT EDWARD WDirectorJul 11Option Exercise37.0925,000927,25058,124Jul 11 05:56 PM
BARNHOLT EDWARD WDirectorJul 11Sale97.2525,0002,431,13333,124Jul 11 05:56 PM
Rencher BradleyEVP & GM, Digital MarketingJul 01Sale95.4637,5623,585,62747,269Jul 01 05:38 PM
ROWLEY RICHARDVP, Corp. Controller & CAOJul 01Sale95.6827125,9291,348Jul 01 04:13 PM
LAMKIN BRYANEVP & GM, Digital MediaJul 01Sale95.049,616913,90523,665Jul 01 04:10 PM
WARNOCK JOHN ECo-Chairman of the BoardJun 30Sale95.154,000380,605581,115Jul 01 04:09 PM
ROSENSWEIG DANIELDirectorJun 29Sale92.9819,3001,794,57419,268Jul 11 04:57 PM
Lewnes AnnEVP, Chief Marketing OfficerJun 24Sale92.394,000369,56046,828Jun 24 04:32 PM
Lewnes AnnEVP, Chief Marketing OfficerMay 27Sale99.404,000397,59650,828May 31 04:09 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryMay 10Sale95.099,466900,16736,409May 11 04:17 PM
Lewnes AnnEVP, Chief Marketing OfficerApr 29Sale92.894,000371,56054,828May 02 04:29 PM
SEDGEWICK ROBERTDirectorApr 12Option Exercise0.003,426079,347Apr 13 05:22 PM
CANNON MICHAEL RDirectorApr 12Option Exercise0.003,426033,124Apr 13 05:20 PM
WARNOCK JOHN ECo-Chairman of the BoardApr 12Option Exercise0.003,4260581,129Apr 14 04:49 PM
CALDERONI FRANKDirectorApr 12Option Exercise0.003,426021,051Apr 14 04:47 PM
BARNHOLT EDWARD WDirectorApr 12Option Exercise0.003,426033,124Apr 14 04:45 PM
Desmond LauraDirectorApr 12Option Exercise0.003,426021,051Apr 14 04:43 PM
BURGESS ROBERT KDirectorApr 12Option Exercise0.003,426038,124Apr 14 04:42 PM
Banse AmyDirectorApr 12Option Exercise0.003,426027,791Apr 14 04:36 PM
ROSENSWEIG DANIELDirectorApr 12Option Exercise0.003,426051,568Apr 14 04:34 PM
DALEY JAMES EDirectorApr 12Option Exercise0.003,426028,086Apr 14 04:32 PM
GESCHKE CHARLES MCo-Chairman of the BoardApr 12Option Exercise0.003,4260299,973Apr 14 04:27 PM
Barlow Kelly JDirectorApr 12Option Exercise0.003,42603,426Apr 13 06:23 PM
WARNOCK JOHN ECo-Chairman of the BoardApr 12Sale93.295,000466,458577,703Apr 12 05:32 PM
ROWLEY RICHARDVP, Corp. Controller & CAOApr 09Option Exercise0.002,81702,817Apr 12 05:34 PM
NARAYEN SHANTANUPresident and CEOApr 01Option Exercise34.0322,422763,021321,394Apr 01 07:31 PM
DALEY JAMES EDirectorApr 01Option Exercise33.825,000169,10029,660Apr 01 07:35 PM
DALEY JAMES EDirectorApr 01Sale95.005,000475,00024,660Apr 01 07:35 PM
NARAYEN SHANTANUPresident and CEOApr 01Sale94.8522,4222,126,678298,972Apr 01 07:31 PM
ROWLEY RICHARDVP, Corp. Controller & CAOApr 01Sale95.058,780834,5500Apr 01 07:28 PM
ValueAct Holdings, L.P.DirectorMar 31Sale93.992,767,739260,127,4666,000Mar 31 05:43 PM
DALEY JAMES EDirectorMar 30Option Exercise33.822,84096,04927,500Apr 01 07:35 PM
ValueAct Holdings, L.P.DirectorMar 30Sale93.764,000,000375,040,0002,773,739Mar 31 05:43 PM
DALEY JAMES EDirectorMar 30Sale94.002,840266,96024,660Apr 01 07:35 PM
ValueAct Holdings, L.P.DirectorMar 29Sale92.971,965,580182,739,9736,773,739Mar 31 05:43 PM
ValueAct Holdings, L.P.DirectorMar 28Sale92.53100,0009,253,0008,739,319Mar 28 05:06 PM
ValueAct Holdings, L.P.DirectorMar 24Sale92.51821,80876,025,4588,839,319Mar 28 05:06 PM
ROWLEY RICHARDVP, Corp. Controller & CAOMar 24Sale92.464,146383,3498,780Mar 25 05:06 PM
Morris DonnaEVP, Cust. & Emp. ExperienceMar 22Sale93.0025,0002,325,00074,008Mar 23 04:38 PM
GESCHKE CHARLES MCo-Chairman of the BoardMar 21Option Exercise42.6125,0001,065,250321,547Mar 23 04:33 PM
WARNOCK JOHN ECo-Chairman of the BoardMar 21Sale92.709,000834,309587,703Mar 23 04:35 PM
GESCHKE CHARLES MCo-Chairman of the BoardMar 21Sale92.4825,0002,311,875296,547Mar 23 04:33 PM
SHPG Shire plc daily Stock Chart
SHPG [NASD]
Shire plc
Index- P/E66.24 EPS (ttm)2.76 Insider Own0.10% Shs Outstand306.12M Perf Week0.99%
Market Cap55.98B Forward P/E10.52 EPS next Y17.38 Insider Trans0.00% Shs Float181.19M Perf Month10.81%
Income603.50M PEG5.72 EPS next Q3.40 Inst Own22.80% Short Float0.52% Perf Quarter5.18%
Sales11.40B P/S4.91 EPS this Y-65.50% Inst Trans-1.84% Short Ratio0.89 Perf Half Y-4.52%
Book/sh96.08 P/B1.90 EPS next Y15.15% ROA0.60% Target Price239.00 Perf Year14.15%
Cash/sh1.77 P/C103.21 EPS next 5Y11.58% ROE1.30% 52W Range149.95 - 209.22 Perf YTD7.34%
Dividend0.80 P/FCF- EPS past 5Y-12.80% ROI2.10% 52W High-12.59% Beta1.56
Dividend %0.44% Quick Ratio0.50 Sales past 5Y22.30% Gross Margin66.50% 52W Low21.96% ATR3.44
Employees23906 Current Ratio1.00 Sales Q/Q121.80% Oper. Margin8.40% RSI (14)65.84 Volatility1.56% 1.65%
OptionableYes Debt/Eq0.79 EPS Q/Q7.20% Profit Margin2.90% Rel Volume0.62 Prev Close181.29
ShortableYes LT Debt/Eq0.69 EarningsFeb 16 BMO Payout0.00% Avg Volume1.06M Price182.88
Recom1.70 SMA205.74% SMA506.88% SMA2000.24% Volume656,050 Change0.88%
Dec-02-16Initiated Societe Generale Buy
Sep-26-16Downgrade HSBC Securities Buy → Hold
Jun-03-16Reiterated Jefferies Buy $223 → $262
May-26-16Initiated Stifel Buy $230
May-06-16Initiated Liberum Buy
Feb-26-16Initiated Cantor Fitzgerald Buy
Feb-10-16Upgrade RBC Capital Mkts Sector Perform → Outperform $240 → $240
Feb-10-16Initiated Guggenheim Neutral
Jan-15-16Upgrade BofA/Merrill Neutral → Buy
Jan-12-16Upgrade Credit Suisse Neutral → Outperform
Jan-12-16Reiterated RBC Capital Mkts Sector Perform $248 → $240
Nov-17-15Upgrade Leerink Partners Mkt Perform → Outperform $239
Nov-03-15Upgrade HSBC Securities Hold → Buy
Oct-26-15Reiterated RBC Capital Mkts Sector Perform $263 → $248
Oct-14-15Initiated Northland Capital Outperform $288
Sep-30-15Upgrade HSBC Securities Reduce → Hold
Aug-06-15Downgrade Exane BNP Paribas Outperform → Neutral
Jul-16-15Resumed Berenberg Buy
Apr-29-15Initiated Exane BNP Paribas Outperform
Jan-26-15Reiterated RBC Capital Mkts Sector Perform $238 → $248
Feb-27-17 06:00AM  Drugmakers Eye $35B Market Amid Obesity Crisis at Investopedia
01:01AM  argenx announces extension of therapeutic antibody alliance with Shire GlobeNewswire
Feb-24-17 04:42PM  SHIRE PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
01:21PM  NASH Is Todd Hagopian's Top Biotech Sub-Sector For 2017 at Forbes
10:02AM  Patient Dies In Roche Hemophilia Study at Investopedia
08:15AM  Blog Coverage Novartis Gains Priority Review from the FDA for its Cancer Drug Zykadia as a Frontline Treatment for ALK-positive Non-Small Cell Lung Cancer Accesswire
07:17AM  CHMP Recommends EU Conditional Marketing Authorisation for Natpar® (Parathyroid Hormone) for Patients with Chronic Hypoparathyroidism PR Newswire
Feb-23-17 09:20AM  Biotech Movers: Shire Rises on Encouraging Angioedema Results
04:11AM  New England Journal of Medicine Publishes Phase 1b Results for Shire's Investigational Treatment for Hereditary Angioedema, a Rare Genetic Disease PR Newswire
02:00AM  Shire Launches 'Rare Count' Campaign to Personalize the Global Impact of Rare Diseases PR Newswire
Feb-22-17 04:56PM  SHIRE PLC Files SEC form 10-K, Annual Report
03:13PM  Momenta Tops Q4 Earnings, Shares Down on Warning Letter
11:55AM  Shire Plc :SHPG-US: Earnings Analysis: 2016 By the Numbers : February 22, 2017
11:05AM  Momenta 4Q Net 60 Cents a Share at Investopedia
Feb-21-17 02:01PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
09:27AM  Shire Plc :SHPG-US: Earnings Analysis: Q4, 2016 By the Numbers : February 21, 2017
Feb-20-17 09:57AM  3 Stocks to Invest in Big Pharma at Motley Fool
Feb-17-17 02:04PM  Shire (SHPG) Beats on Q4 Earnings, Sales; Gives Upbeat View
01:50PM  Shire PLC 4Q Earnings, Revenue Beat Street at Investopedia
01:08PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
Feb-16-17 04:28PM  Drugmaker Shire Tops Q4 Views; Stock Pops To Six-Week High
08:14AM  Shire beats Street 4Q forecasts
07:52AM  Shire Reports Full Year 2016 Results With Record Revenue; Positioned for Continued Strong Growth Driven by Best-in-class Rare Disease Pipeline PR Newswire
07:25AM  Shire Beats Full-Year Earnings Estimates, Sees Robust 2017 Growth
Feb-15-17 04:24PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
12:49PM  Amicus Therapeutics Updates Migalastat Drug at Investopedia
Feb-14-17 07:30AM  Shire to Highlight Advancements in Rare Genetic Diseases PR Newswire
Feb-08-17 10:04AM  Shire ViroPharma Sued By FTC Over Sham FDA Filings at Investopedia
Feb-07-17 04:05PM  FTC says Shire unit used illegal tactics to block generic competition at bizjournals.com
03:42PM  Shire Responds to U.S. Federal Trade Commission Civil Action PR Newswire
10:45AM  Hemophilia Drug Market Competitive Ramps Up at Investopedia
Feb-02-17 10:40AM  5 Drugmakers Battle Over the $10 Billion Hemophilia Market at Motley Fool
Feb-01-17 03:49PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
01:39PM  New Data From Shire Aim to Help Close the Diagnosis and Treatment Gap for People With Hemophilia PR Newswire
Jan-27-17 12:20PM  Keeley All Cap Value Fund Comments on Shire
Jan-26-17 08:25AM  Drug Giants May Benefit From China Drug Inclusion at Investopedia
Jan-25-17 01:10PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
Jan-23-17 11:27AM  5 Stupendously Expensive Cancer Drugs at Motley Fool
Jan-20-17 05:50PM  Shire's (SHPG) ADHD Candidate's NDA Accepted by FDA
Jan-19-17 10:00AM  Is Shire plc a Great Stock for Value Investors?
07:00AM  U.S. FDA Acknowledges Receipt of Shire's New Drug Application for SHP465 for ADHD PR Newswire
Jan-18-17 12:37PM  Alcobra Stock Down on Poor Late-Stage Data on ADHD Drug
Jan-17-17 12:24PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
Jan-13-17 11:56AM  FTSE 100 continues record run, rising for 14th day in a row at MarketWatch
Jan-12-17 02:34PM  KemPharm CEO On Recent Results, Catalysts And Prospects: 'ADHD Is By Far The Larger Market Opportunity'
02:00PM  Lawsuit accuses Shire of monopolizing market for ADHD drug at bizjournals.com
12:20PM  Drug makers, auto stocks yank European stocks lower for first time in 3 days at MarketWatch
Jan-11-17 08:23PM  PRESS DIGEST- Financial Times - Jan 12 Reuters
04:32PM  [$$] Shire to Pay $350 Million to Settle Dermagraft Kickback Allegations at The Wall Street Journal
02:45PM  Pharmaceutical company agrees to landmark settlement in Tampa federal court at bizjournals.com
01:40PM  Trump slams drug industry at press conference, sending biotech stocks tumbling at bizjournals.com
12:21PM  FTSE 100 logs 10th day of all-time highs at MarketWatch
Jan-10-17 01:17PM  Shire CEO: Our innovation score is very high
Jan-09-17 05:35PM  Martin Whitman Invests in Homebuilder in 4th Quarter
01:55PM  Merrimack Pharma to Sell Cancer Drugs for $1B at Investopedia
Jan-06-17 04:22PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
10:46AM  For Shire PLC (ADR) (SHPG) Securing Hemophilia Market With Long Acting Version Is Crucial at Insider Monkey
Jan-05-17 02:40PM  Here's what to expect from Mass. biotechs at this weekend's J.P. Morgan conference at bizjournals.com
12:52PM  Cooperman's best ideas: 14 stock picks
12:03PM  Billionaire James Dinan Betting On These Stocks To Recover Losses at Insider Monkey
Jan-04-17 05:14PM  SHIRE PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
09:30AM  Shire to Present at the 35th Annual J.P. Morgan Healthcare Conference PR Newswire
Jan-03-17 05:31PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
Dec-30-16 06:17AM  Pharma Stock Roundup: Cempra Plunges to 52-Week Low, Shire Drug Label Expanded
Dec-28-16 10:18AM  Shire Gets FDA Approval for Label Expansion of Adynovate
08:15AM  Blog Coverage Shire Receives FDA Approval for ADYNOVATE for Use in Children Under 12 Years Accesswire
Dec-27-16 07:00AM  Shire Announces FDA Approval of Adynovate® for use in Children and Surgical Settings PR Newswire
06:00AM  Most Important Mergers and Acquisitions of 2016 at Investopedia
Dec-23-16 05:12PM  Third Avenue Value Fund Buys 2 Stocks and Adds to 2 Positions in Q4
Dec-22-16 11:20AM  Shire Could Have A Game Changer In The Making
11:10AM  AmerisourceBergen urges stockholders to reject unsolicited 'mini-tender' offer at bizjournals.com
Dec-19-16 03:59PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
07:35AM  The Most Expensive Drugs of 2016 at Motley Fool
Dec-16-16 01:04PM  5 Biggest Acquisitions of 2016 at Motley Fool
Dec-15-16 01:00PM  American Blood Gives a Boost to Asias Most Valuable Drugmaker at Bloomberg
11:48AM  Shire PLC (ADR) (SHPG) Looks To Xenetic Biosciences Inc (XBIO) To Cement Hemophilia Market Share at Insider Monkey
09:47AM  A Primer On NASH
01:39AM  Is Shinhan Financial Group Co., Ltd. (ADR) (SHG) Going To Burn Investors? at Insider Monkey
Dec-09-16 04:12PM  Allergan Unhappy with Patent Office Decision to Allow Mylan Challenge to Restasis Patents
03:38PM  Best Midcap Stocks To Buy According To Billionaire Loeb at Insider Monkey
Dec-05-16 08:15AM  Blog Coverage Shire Announced Successful Results of its Phase III Investigational Study of VONVENDI(TM) Accesswire
Dec-04-16 06:05PM  5 Healthcare Stocks Billionaires Love The Most at Insider Monkey
Dec-02-16 05:21PM  Shire Reports on Four Decades of Real-World Safety Experience With FEIBA® PR Newswire
04:32PM  Shire Loses Ground To Allergan In Thanksgiving Week Dry-Eye Scripts
04:16PM  SHIRE PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
11:02AM  Topline Results of Phase 3 Investigational Study of VONVENDI Meets Primary Endpoint Effectively Controlling Bleeding and Blood Loss During Surgical Procedures PR Newswire
08:36AM  Coverage initiated on Shire plc by Societe Generale
Dec-01-16 04:29PM  John Paulson's Largest 3rd Quarter Trades
12:42PM  Is Smart Money Turning More Positive on Bed Bath & Beyond Inc. (BBBY)? at Insider Monkey
09:30AM  What Does Smart Money Think about Avery Dennison Corp (AVY)? at Insider Monkey
Nov-30-16 09:58AM  Momenta/Shire's Humira Biosimilar Meets Study Objective
Nov-29-16 08:23AM  Momenta stock jumps nearly 10% on positive late-stage results for Humira biosimilar at MarketWatch
Nov-28-16 04:34PM  Amicus Tumbles on Lengthy Delay to U.S. Fabry Drug FDA Filing Plan
01:11PM  5 Healthcare Stocks Hedge Funds Are Dumping Like Crazy at Insider Monkey
Nov-25-16 05:18AM  Actelion Soars as Johnson & Johnson 'Makes Takeover Proposal'
Nov-24-16 03:31PM  Do Hedge Funds Love PulteGroup, Inc. (PHM)? at Insider Monkey
Nov-23-16 04:00PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
01:42PM  Top Investors Are Abandoning Shire PLC (SHPG) in Droves at Insider Monkey
Nov-22-16 10:29AM  Shire to lease Genzyme headquarters, plans to hire another 400 at bizjournals.com
07:00AM  Shire to Establish Rare Disease Innovation Hub in Cambridge, Mass. PR Newswire
Shire plc, a biopharmaceutical company, together with its subsidiaries, researches, develops, licenses, manufactures, markets, distributes, and sells pharmaceutical products. It offers various products for the treatment of attention deficit hyperactivity disorder (ADHD), including VYVANSE/VENVANSE, a pro-drug stimulant; ELVANSE/TYVENSE; INTUNIV, an alpha-2A receptor agonist; EQUASYM, a methylphenidate hydrochloride; and ADDERALL XR, an extended release treatment for ADHD. The company also provides PENTASA and LIALDA/MEZAVANT for ulcerative colitis treatment; and RESOLOR, a 5-HT4 receptor agonist for oral symptomatic treatment of chronic constipation in women. In addition, it offers FOSRENOL, a phosphate binder for use in end-stage renal disease receiving dialysis; and XAGRID for the reduction of elevated platelet counts in at-risk essential thrombocythemia patients, as well as for the treatment of thrombocythemia. Further, the company provides REPLAGAL for the treatment of Fabry disease; ELAPRASE for the treatment of hunter syndrome; VPRIV for the treatment of type 1 Gaucher disease; and FIRAZYR for the symptomatic treatment of acute attacks of hereditary angioedema. Additionally, it offers FOSRENOL for the treatment of hyperphosphatemia in end stage renal disease; XAGRID for the reduction of elevated platelet counts; and CINRYZE, a C1 esterase inhibitor therapy for routine prophylaxis against hereditary angioedema. The company also licenses its patented antiviral products for human immunodeficiency virus and hepatitis B virus. Shire plc markets its products directly to government hospitals, clinics, pharmacies, and other agencies; and through wholesalers and distributors. The company sells its products in North America, the United Kingdom, the Republic of Ireland, and internationally. Shire plc has research collaboration with Santaris Pharma A/S. The company was founded in 1986 and is headquartered in Dublin, Ireland.